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Abstract 
The primary purpose of this study was to evaluate the construct validity of the 
Questionnaire to Identify Knee Symptoms (QuIKS) measurement scale among individuals 
with chronic knee symptoms consistent with osteoarthritis.  Construct validity was 
assessed using tests of convergent and discriminative validity on 15 pre-specified 
hypotheses.  The secondary objective was to determine the internal consistency reliability 
of the QuIKS.  One hundred and five individuals recruited in select physiotherapy clinics 
from across Canada were mailed the QuIKS and five other health questionnaires.  Fifty-
five individuals completed the questionnaire package.  While none of the pre-specified 
construct validity hypotheses were met, nine of the validity analyses supported the 
construct validity of the QuIKS. The results also supported the internal consistency 
reliability of the QuIKS, as Cronbach’s alpha for the scale was 0.81.  Overall, the QuIKS 
appears to be a valid tool to quantify illness behaviour in individuals with chronic knee 
symptoms.   
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Chapter 1 
1 Introduction 
Knee osteoarthritis (OA) affects all the tissues of the synovial joint, including the 
cartilage, bone, meniscus, ligament, tendon, and synovium (Lane et al., 2011).  It is 
estimated that 13% of Canadians and over 300 million people worldwide have OA 
(Bombardier, Hawker, & Mosher, 2011; Vos et al., 2017).  OA is also a major 
contributor to disability, as it is ranked as the 10th leading cause of disability in Canada 
and 12th worldwide (Vos et al., 2017).  Additionally, the number of individuals with 
OA, and the disability attributed to this condition, is increasing (Hay et al., 2017).  
Knee OA has various modifiable and non-modifiable risk factors.  Modifiable risk 
factors, such as obesity and muscle dysfunction, can be influenced through 
conservative interventions, and thus are targets for the management of knee OA.  
While total joint replacement is reserved for individuals with advanced disease or 
severe pain and functional limitations (Nelson et al., 2014), most knee OA should be 
managed with education and self-management, weight management, exercise, and 
corticosteroid injections (McAlindon et al., 2014).  However, due to the inability of 
current diagnostic methods to detect early-stage disease, these treatment strategies 
have not been comprehensively evaluated in early-stage knee OA, where they are 
likely to be most effective at preventing disability.    
The diagnostic criteria for OA are widely debated, but there has been a recent shift 
away from imaging-based diagnoses.  OA is now considered a clinical diagnosis and 
imaging is only to be utilized to exclude competing differential diagnoses (Wenham, 
Grainger & Conaghan, 2014).  Major guidelines now support the diagnosis of knee 
OA based solely on clinical symptoms and examination findings (Altman et al., 1986; 
National Institute for Health and Care Excellence, 2008; Zhang et al., 2010). 
Despite imaging no longer being required to diagnose knee OA, screening attempts 
have been largely ineffective.  Current diagnostic methods are designed to identify 
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late-stage disease (Jordan, Luta, Renner, Dragomir, Hochberg & Fryer, 1997; 
O’Reilly, Muir & Doherty, 1996), and thus are not ideal for screening.  Patient self-
report of symptoms is a cost-efficient method of screening for disease and previous 
attempts have been made to create screening instruments for knee OA (LaValley et al., 
2001; Quintana et al., 2007; Roux et al., 2008; Marra et al., 2007).   However, these 
instruments were developed from current diagnostic criteria and therefore unable to 
identify the early-onset of disease.  An effective screening test should be sensitive to 
early stages of a disease, when the subsequent course of the disease may still be 
altered (Fletcher, Fletcher & Fletcher, 2014).  Therefore, a new screening instrument 
that does not rely on late-stage disease criteria would be of benefit.  
A new screening tool, the Questionnaire to Identify Knee Symptoms (QuIKS) has 
been developed to identify individuals with knee OA (Clark, Chesworth, Speechley, 
Petrella, & Maly, 2014).  The QuIKS attempts to quantify illness behaviours of an 
individual with chronic knee pain (Hamilton, Wong, Gignac, Davis, & Chesworth, 
2017).  The QuIKS has undergone psychometric evaluation, including reliability and 
validity testing (Clark, Chesworth, Speechley, Petrella, & Maly, 2014, Hamilton et al., 
2015).  However, further psychometric testing of the QuIKS has been recommended 
(Hamilton, Wong, Gignac, Davis, & Chesworth, 2017), including evaluation of 
construct validity and reliability. 
The QuIKS was developed as a discriminative measure to distinguish individuals 
along a continuum of illness behaviour.  As the QuIKS was designed to measure the 
hypothetical construct of illness behaviour (Hamilton, Wong, Gignac, Davis, & 
Chesworth, 2017), it is important to understand the psychometric properties of this 
measure.  While the QuIKS instrument has undergone preliminary testing of internal 
consistency reliability and construct validity in the same sample used to develop the 
measure, the developers recommended further evaluation in an independent sample of 
individuals with chronic knee symptoms (Clark, Chesworth, Speechley, Petrella, & 
Maly, 2014; Hamilton et al., 2015; Hamilton, Wong, Gignac, Davis, & Chesworth, 
2017).   
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Construct validation determines if the measurement tool is an adequate measure of an 
unobservable construct (Cronbach & Meehl, 1955).  A process of specific, a priori 
hypothesis testing is recommended to evaluate construct validity (Smith, 2005; 
Terwee et al., 2007).  Convergent and discriminative validity tests are two commonly 
used construct validation methods (Cronbach & Meehl, 1955; Streiner, Norman, & 
Cairney, 2015).  Convergent validation attempts to hypothesize and quantify how 
closely a measurement scale of the theoretical construct is related to other constructs 
and measures, and typically utilizes a correlation analysis undertaken at a single time-
point (Streiner, Norman, & Cairney, 2015).  Discriminative validation is used to 
distinguish between predictably different individuals or groups and requires the 
formulation of a hypothesis about which known-groups of people will have higher or 
lower amounts of the construct under investigation, observed via scores on the 
measurement index (Streiner, Norman, & Cairney, 2015).  In addition to validity, a 
measurement scale should demonstrate reliability (Carmines & Zeller, 1979).  One 
type of reliability is evaluated using Cronbach’s alpha, a measure of internal 
consistency reliability (Cronbach, 1951). 
The QuIKS could potentially be used as a screening tool to identify individuals with 
early-stage knee OA.  However, the psychometric properties of the QuIKS must first 
be established.  The QuIKS, if proven to have adequate validity and reliability, could 
be further evaluated as a diagnostic tool.  The ability to identify the onset of knee OA 
could improve implementation of effective interventions in the early stages of disease, 
potentially slowing the progression of disease and preventing chronic disability.  
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1.1 Objectives 
The overall objective of this study was to assess the psychometric properties of a self-
administered questionnaire designed to identify the degree of illness behaviour in 
individuals with knee symptoms consistent with knee OA, and thus, aid in the 
validation of a tool for use in the clinical and research environment.    
Specific objectives to achieve this goal were as follows: 
 
Objective 1:  
The primary objective was to evaluate the construct validity of the QuIKS measure in 
a sample of adults with knee symptoms consistent with knee OA.  
Objective 1A: To evaluate the convergent validity of the QuIKS measure. 
Objective 1B: To evaluate the discriminative validity of the QuIKS measure.  
 
Objective 2: 
The secondary objective was to assess the internal consistency reliability of the QuIKS 
measure in the same sample of individuals.  
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Chapter 2 
2 Background Literature Review 
Osteoarthritis (OA) is a highly prevalent disease and a leading cause of disability in 
Canada and worldwide (Vos et al., 2017).  Early diagnosis of knee OA could result in 
less disability attributed to this disease (Burstein, 2009), but current diagnostic 
methods are only able to identify individuals with late-stage knee OA (Jordan, Luta, 
Renner, Dragomir, Hochberg & Fryer, 1997; O’Reilly, Muir & Doherty, 1996).  This 
literature review will highlight the epidemiology, diagnosis, and management of knee 
OA, as well as the potential use of patient self-report questionnaires as screening tools.  
More specifically, a recap of the development of the Questionnaire to Identify Knee 
Symptoms will be presented along with a review of psychometric properties, namely 
construct validity and internal consistency reliability. 
2.1 Osteoarthritis 
2.1.1 Definition 
OA is a complex disease that is difficult to define (Symmons, Mathers & Pfleger, 
2006).  OA was originally defined as a collection of disorders affecting the articular 
cartilage and subchondral bone of synovial joints (Altman et al., 1986).  Newer 
conceptualizations of the disease acknowledge the heterogeneous presentations of OA, 
including the role of inflammation in disease pathogenesis (Kraus, Blanco, Englund, 
Karsdal & Lohmander, 2015; National Institute for Health and Care Excellence, 
2014).  There is increasing acceptance that OA does not represent a single joint 
disorder, but rather is a disease spectrum with multiple subsets leading to similar 
clinical and pathological findings (Hart & Spector, 1995).  There has been a recent 
shift towards viewing OA as a syndrome with multiple phenotypes (Bruyere et al., 
2015).  Clinical, laboratory, imaging, and etiologic phenotypes have been proposed for 
knee OA (Deveza, Melo, Yamato, Mills, Ravi & Hunter, 2017).  As such, knee OA is 
likely best defined as a disease of the whole-joint organ, affecting all the tissues of the 
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synovial joint, including the cartilage, bone, menisci, ligament, tendon, and synovium 
(Lane et al., 2011).  
2.1.2 Epidemiology 
It is estimated that over 300 million individuals worldwide have OA (Vos et al., 2017).  
OA has been shown to have a high prevalence wherever such statistics are available 
(Reginster, 2002), but estimates will vary depending on the case definition of OA 
utilized (Zhang & Jordan, 2010; Felson, Naimark, Anderson, Kazis, Castelli, & 
Mennan, 1987; Jordan et al., 2007; Lawrence et al., 2008; Quintana, Arostegui, 
Escobar, Azkarate, Goenaga, & Lafuente, 2008).  Canadian prevalence estimates also 
differ based on the choice of OA definition (Kopec et al., 2007).  The prevalence of 
OA was 10.8% in 2001 in the British Columbian population (Kopec et al., 2007), 
while another study found roughly 1 in 8 Canadians, or 13% of the population, had 
osteoarthritis in 2010 (Bombardier, Hawker, & Mosher, 2011).   
OA is the most common joint disorder in the United States (Felson et al., 2000) with 
the knee being the most commonly affected (Newman et al., 2003).  American 
prevalence estimates range from 10-19%, depending on the study sample and case 
definition used (Felson et al., 198; Jordan, Linder, Renner, & Fryer, 1995; Jordan et 
al., 2007; Jordan, Linder, Renner, & Fryer, 1995; Jordan et al., 2007).  These 
American figures are comparable to European and Asian estimates (Arden & Nevitt, 
2006; Tang et al., 2016; Park et al., 2017).  One global review found the knee OA 
prevalence to be 24% worldwide, but also provided individual estimates of self-
reported, radiographic, and symptomatic knee OA (Pereira, Peleteiro, Araujo, Branco, 
Santos, & Ramos, 2011). 
There is limited OA incidence data currently available (Zhang & Jordan, 2010). Data 
from the Framingham Osteoarthritis Study suggests that approximately 8% of women 
and 4% of men develop symptomatic knee OA per year (Felson et al., 1995). The 
estimated lifetime risk of developing knee OA has been reported in the range of 14-
44%, depending on the case definition, study sample, and methodology utilized 
(Murphy et al., 2008; Losina et al., 2013).  
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The prevalence of OA is rising worldwide, as a 30% increase in the number of 
prevalent cases was observed between 2006 and 2016 (Vos et al., 2017).  This trend 
has also been observed in Canada.  One study found that prevalence of all forms of 
arthritis has increased from 13.4% to 17.6% between 1994 and 2002, an increase of 
roughly 50% of the percentage of Canadians reporting arthritis (Perruccio, Power, & 
Badley, 2006).  It is expected the prevalence of arthritis in Canada will continue to rise 
with estimates between 21% and 26% by 2021 (Perruccio, Power, & Badley, 2006). 
Another projection found a 47% increase in the prevalence of self-reported arthritis is 
likely by 2031 (Badley, Rothman, & Wang, 1998).  Based on a simulation model used 
in the 2011 report from the Arthritis Alliance of Canada, the projected prevalence of 
specifically OA is 25% of the population by 2040, or over 10 million Canadians 
(Bombardier, Hawker, & Mosher, 2011).  
Kopec et al., (2008) found that incidence rates of OA increased in both British 
Columbian men and women between 1996-97 and 2003-04.  The Arthritis Alliance of 
Canada used these findings in a 2011 report to predict future incidence rates of OA in 
the entire Canadian population (Bombardier, Hawker, & Mosher, 2011).  Compared to 
37,342 new diagnoses of OA in 2010, 469,467 new diagnoses of OA are predicted for 
2040, which equates to a new OA diagnosis every 60 seconds.  All available 
prevalence and incidence estimates suggest that OA will affect a large number of 
Canadians in the near future. 
2.1.3 Burden 
Knee OA has placed a large burden on health care systems worldwide.  In the 2016 
Global Burden of Disease Study, OA was the 12th leading cause of years lived with 
disability in the world (Vos et al., 2017).  OA is one of the most common 
musculoskeletal disorders and ranks highly as a cause of morbidity and use of health 
services (American College of Rheumatology, 2000; Reginster, 2002; Picavet & 
Hazes, 2003). A report from the Centre for Disease Control and Prevention found that 
arthritis is the most common cause of disability in the American population, affecting 
approximately 8.6 million individuals (Centre for Disease Control and Prevention, 
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2009).  Over 350,000 total joint replacements are performed annually in the United 
States for knee and hip OA (Arden & Nevitt, 2006).  This problem is compounded by 
population projections that show a drastic increase in the future population of persons 
over the age of 60 years (United Nations Department of Economic and Social Affairs, 
Population Division, 2017).  This is likely to further increase the number of 
individuals with knee OA and overall economic burden (Woolf & Pfleger, 2003; Sun, 
Wu, & Kalunian, 2007). One study projected that by 2030, 25% of the total US 
population and 33% of the working adult population will have arthritis (Hootman & 
Helmick, 2006), of which a large proportion will have OA, causing significant impact 
throughout the entire economy.   
In Canada, arthritis of all forms is the leading cause of disability and health care 
utilization (Health Canada, 2003), with annual cost estimates of $4.4 billion (Health 
Canada, 2002).  OA in particular is the 10th leading cause of years lived with disability 
in Canada (Vos et al., 2017).  An individual with OA typically costs the Canadian 
health care system around $5700 USD per annum (Maetzel, Li, Pencharz, Tomlinson, 
& Bombardier, 2004), which would rise by roughly $8600 if undergoing joint 
replacement (Hawker et al., 2009).   
Knee OA also causes employed adults to reduce working hours and/or miss work 
altogether (Gignac, Cao, Lacaille, Anis, & Badley, 2008), which contributes to the 
overall economic burden through lost productivity.  A 2010 estimate of the total 
economic burden of $27.5 billion was attributed to roughly 4.5 million cases of knee 
and hip OA (Bombardier, Hawker, & Mosher, 2011).  However, Canada too is 
expected to see a rise in the incidence of new OA cases, equating to a staggering total 
economic burden of approximately $1.5 trillion by 2040 (Bombardier, Hawker, & 
Mosher, 2011).  A large portion of this is due to the projection that about 30% of the 
Canadian workforce will have difficulty working due to OA (Bombardier, Hawker, & 
Mosher 2011).  There is a clear need for a better understanding of OA to help reduce 
this potentially crippling financial burden. 
  
	  	   9 
2.2 Risk Factors for Knee Osteoarthritis 
Knee OA is a complex condition that has many differing and potentially interacting 
risk factors.  Several risk factors for the development and progression of this multi-
factorial condition have been identified in the literature. Some risk factors, such as sex, 
age, previous trauma, and knee alignment, cannot be altered through conservative 
interventions, and are thus considered non-modifiable risk factors.  Modifiable risk 
factors, such as obesity and muscle dysfunction, can be influenced through 
conservative interventions.  Non-modifiable risk factors may provide an opportunity to 
identify individuals at increased risk of developing knee OA, while modifiable factors 
may provide unique intervention targets to limit onset and progression of disease and 
provide symptomatic management for patients. 
2.2.1 Non-Modifiable Risk Factors 
Sex 
The prevalence and incidence of knee OA is significantly greater in women than men 
(Oliveria, Felson, Reed, Cirillo, & Walker, 1995).  Females are two times more likely 
than men to have OA and typically exhibit higher levels of disability (Statistics 
Canada, 2007).  Females are also more likely to have more severe knee OA (Srikanth, 
Fryer, Zhai, Winzenberg, Hosmer, & Jones, 2005).  However, sex does not seem to 
affect the progression of knee OA (Felson et al., 1995; Schouten, van den Ouweland, 
& Valkenburg, 1992).  Higher disease rates and severity in females may be caused by 
the role of estrogen (Zhang & Jordan, 2010) or due to sex differences in bone strength, 
alignment, neuromuscular strength, pregnancy, and ligament laxity (Johnson & 
Hunter, 2014).  
Age 
Age is a strong risk factor for knee OA (Felson et al., 2000; Lawrence et al., 2008).  
The prevalence of knee OA significantly increases with age (Issa & Sharma, 2006).  
Prevalence and incidence rates of both radiographic and symptomatic OA in general 
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increase in the aging population (Arden & Nevitt, 2006).  As individuals age, it is 
likely joints become more vulnerable to biomechanical insult and have a decreased 
reparative capacity (Arden & Nevitt, 2006).  Moreover, age-related reductions in 
physical activity, muscle weakness, and knee joint laxity may also contribute to 
increased rates of knee OA in the elderly (Loeser & Shakoor, 2003; Rudloph, Schmitt, 
& Lewek, 2007).  However, the exact mechanism(s) by which increasing age affects 
knee OA is not currently understood (Johnson & Hunter, 2014).   
Trauma 
Knee injury is one of the strongest risk factors for OA (Zhang & Jordan, 2010) and 
individuals who suffer a knee injury are at an increased risk of early-onset disease 
(Johnson & Hunter, 2014).  Ruptures of the anterior cruciate ligament, meniscal tears 
and articular cartilage injuries are strongly linked to the development of knee OA 
(Roos, Ostenberg, Roos, Ekdahl, & Lohmander, 2001; Lohmander, Ostenberg, 
Englund, & Roos, 2004; Lohmander, Englund, Dahl, & Roos, 2007).  Anterior 
cruciate ligament tears appear to be the most likely to result in knee OA, but the exact 
mechanism leading to this increased risk is poorly understood (Slauterbeck, Kousa, & 
Clifton, 2009).  It is possible that OA develops as a result of the tissue damage during 
the initial injury (Buckwalter, 2002; Friel & Chu, 2013) or as a result of altered 
loading patterns that develop secondary to the knee injury (Chaudari, Briant, Bevill, 
Koo, & Andriacchi, 2008).  Knee OA prevalence rates of up to 70% post-injury are 
commonly reported in the literature (Johnson & Hunter, 2014), but recent evidence 
suggests these figures may be overestimated.  One study found a 13% prevalence of 
knee OA after an isolated anterior cruciate ligament rupture, but a higher prevalence of 
21-40% if a meniscal injury occurred in combination (Oiestad, Engebretsen, & 
Storheim, 2009).   
Alignment 
Knee malalignment, or varus and valgus alignment, is a risk factor for the progression 
of knee OA.  It is theorized that malalignment leads to abnormal mechanical forces 
through the knee joint (Johnson & Hunter, 2014).  Varus alignment, or being bow-
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legged, is typical in patients with medial compartment knee OA (Hunter, Sharma, & 
Skaife, 2009).  Abnormal alignment has been shown to be strongly associated with 
increased structural damage in the compartment under greatest mechanical stress 
(Sharma, Song, Felson, Cahue, Shamiyeh, & Dunlop, 2001).  For example, individuals 
with varus malalignment were four times more likely to experience progression of 
medial compartment knee OA, while individuals with valgus malalignment were five 
times more likely to undergo lateral compartment progression (Cerejo, Dunlop, Cahue, 
Channin, Song, & Sharma, 2002).   
The role of knee alignment in the development of knee OA is less understood than its 
role in disease progression (Johnson & Hunter, 2014; Zhang & Jordan, 2010).  There 
is biomechanical rationale that suggests knee alignment deformities could contribute 
to the development of knee OA, but this has not been well studied (Arden & Nevitt, 
2006).  The Rotterdam study found an increased risk of incident knee OA in varus and 
valgus aligned knees (Brouwer et al., 2007), while no increased risk of knee OA was 
found with knee alignment in the Framingham cohort (Hunter et al., 2007).  This may 
indicate that malalignment is only a risk factor for disease progression and not for 
incident knee OA (Hunter et al., 2007).  It is also possible the degree of malalignment 
may affect the incidence and/or progression of knee OA by influencing the impact of 
other risk factors, such as muscle dysfunction or obesity, thereby altering the load 
profile placed on the knee joint (Hunter, Sharma, & Skaife, 2009). 
2.2.2 Modifiable Risk Factors 
Obesity 
Obesity, as measured by body mass index (BMI), is one of the strongest and most 
established risk factors for knee OA (Felson et al., 2000; Jiang et al., 2012).  The 
association between obesity and knee OA is thought to be a result of both joint 
damage caused by excess joint loads and metabolic factors associated with obesity 
(Arden & Nevitt, 2006).  Nearly two million individuals were followed for 4 years, 
and the incidence of knee OA was 19.5 per 1000 person-years for obese BMI 
individuals, but only 3.7 per 1000 person-years for normal BMI individuals (Reyes, 
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Leyland, Peat, Cooper, Arden, & Prieto Alhambra, 2016).  It has been shown that for 
every 5-unit increase in BMI, there is a 35% increased risk of developing knee OA 
(Jiang et al., 2012), while a 5 kg reduction in body weight decreases the risk by 50% 
(Felson, Zhang, Anthony, Naimark, & Anderson, 1992; Christensen, Bartels, Astrup, 
& Bliddal, 2007). 
The progression of knee OA is also affected by obesity (Felson et al, 2000).  Increased 
weight has been shown to accelerate the structural deterioration of knee OA (Cooper 
et al., 2000).  The risk of total knee arthroplasty is 41% greater in overweight BMI 
individuals and at least 97% greater in obese BMI individuals compared to normal 
weight individuals (Leyland et al, 2016).  As obesity is an established risk factor for 
knee OA development and is increasing in prevalence, it is likely that a greater 
number of individuals will develop knee OA in the future (Johnson & Hunter, 2014). 
Muscle Weakness 
Deficits in muscle strength and activation are a risk factor and common in patients 
with knee OA (Johnson & Hunter, 2014).  It is thought that muscle weakness and 
atrophy may be a product of disuse due to pain-avoidance by an individual with knee 
OA (Zhang & Jordan, 2010). Evidence exists that muscle weakness may influence the 
onset and progression of knee OA (Bennell, Wrigly, Hunt, Lim, & Hinman, 2013).  
The quadriceps femoris muscle is primarily implicated in the genesis of knee OA.  It is 
hypothesized that quadriceps weakness leads to increased loads at the knee joint 
(Slemenda et al., 1998). Increasing muscle strength has been shown to be an effective 
treatment for improving pain and function in knee OA (Bennell, Wrigly, Hunt, Lim, & 
Hinman, 2013) as well as reducing the likelihood of developing knee OA (Slemenda et 
al., 1998).  However, whether muscle strength can attenuate the progression of knee 
OA may depend on the influence of other risk factors, such as joint alignment (Arden 
& Nevitt, 2006).  Currently, the relationship between muscle weakness and knee OA is 
not fully understood (Zhang & Jordan, 2010).  
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2.3 Management of Knee Osteoarthritis 
The management of knee OA is targeted at the modifiable risk factors of the disease.  
Many guidelines for the management of knee OA have been published and are 
generally consistent in their recommendations (McAlindon et al., 2014; Fernandes et 
al., 2013; Hochberg et al., 2012; Nelson, Allen, Golightly, Goode, & Jordan, 2014).  
Patient management should be individualized based on patient expectations, risk 
factors, and pain and disability levels (Fernandes et al., 2013).  One internationally 
developed guideline recommends that education and self-management, weight 
management, exercise, and corticosteroid injections are appropriate for all individuals 
with knee OA (McAlindon et al., 2014).  Individuals with knee OA may also undergo 
surgical intervention if non-surgical interventions fail to adequately manage the 
disease.  While arthroscopic procedures are no longer supported, high tibial 
osteotomies may be of value, and total joint replacement is recommended for 
individuals with end-stage disease or severe pain and functional limitations (Nelson et 
al., 2014; Richmond et al., 2010).  
2.3.1 Education and Self-management 
Education and self-management strategies are recommended as core treatments for all 
individuals with knee OA (McAlindon et al., 2014; Fernandes et al., 2013).  Self-
management strategies are defined as complex behavioural interventions targeted at 
patient education and behaviour modification, which encourage people with chronic 
disease to take an active role in the management of their own condition (Kroon, van 
der Burg, Buchbinder, Osborne, Johnston, & Pitt, 2014).  In 2014, the Cochrane 
Library published a review of 29 randomized controlled trials assessing the 
effectiveness of self-management education programs (Kroon et al., 2014).  Compared 
to usual care for individuals with OA, these interventions may improve self-
management skills, pain, function, and symptoms, but only low to moderate quality 
evidence exists (Kroon et al., 2014).  However, these interventions are unlikely to 
cause harm and thus should be implemented for all patients with knee OA (Kroon et 
al., 2014). 
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2.3.2 Weight Management 
Weight management, defined as addressing weight loss if overweight or obese, is 
considered standard management for knee OA (McAlindon et al., 2014; Fernandes et 
al., 2013).  Weight management encompasses a range of strategies, including dietary 
interventions, increasing physical activity, and eating behaviour education (Fernandes 
et al., 2013).  While weight loss shows only small and likely insignificant 
improvements in pain levels, it has been shown to have a greater impact on disability 
(Christensen, Bartels, Astrup, & Bliddal, 2007). A 5% reduction in total body weight 
over a 20-week period is likely the cut-point to provide significant improvements in 
disability (Christensen et al., 2007).  This improvement appears to be accomplished 
through dietary modification, exercise intervention, or both, which allows patient 
preference to be incorporated into the shared decision-making process (Christensen et 
al., 2007).  
2.3.3 Exercise 
Therapeutic exercise has been widely studied in the management of knee OA.  All 
patients with knee OA should receive an individualized exercise program, which may 
involve resistance exercise, aerobic exercise, and range of motion or stretching 
exercises (McAlindon et al., 2014; Fernandes et al., 2013).  Patients may also perform 
these exercises in aquatic settings, when appropriate.  A 2015 Cochrane Review 
concluded there is high-quality evidence that land-based exercises have short-term 
benefits on knee pain and physical function (Fransen, McConnell, Harmer, Van der 
Esch, Simic, & Bennell, 2015).  While the treatment effects of exercise are considered 
small, they are comparable to the reported effects of non-steroidal anti-inflammatory 
drugs (Fransen et al., 2015).  A more recent Cochrane Review found that exercise may 
help improve pain, function and depression, while also providing a wide range of 
health benefits to people (Hurley et al., 2018).  
A recent systematic review of 48 randomized controlled trials found that exercise 
interventions should focus on a single goal of increasing strength, aerobic capacity, or 
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proprioception and balance (Juhl, Christensen, Roos, Zhang, & Lund, 2014).  A 
stratified meta-analysis based on type of exercise intervention found that quadriceps-
specific exercise, when performed three times a week under supervision, provides the 
most pain reduction (Juhl et al., 2014).  More recently, combination exercise and 
education interventions have been introduced.  One such example is the Good Life 
with osteoArthritis in Denmark (GLA:D) program.  The GLA:D program has been 
administered to over 9800 participants with OA in Denmark and has been found to 
have a significant impact on pain, quality of life, physical function and physical 
activity levels (Skou & Roos, 2017).  This program is currently being implemented 
globally, and preliminary evidence shows meaningful results for people living in 
Canada with OA (Davis et al., 2017).   
2.3.4 Injections 
Patients who do not achieve adequate management of their knee OA through 
education, weight management, and exercise may elect to receive intra-articular 
injections.  Intra-articular injections may include corticosteroid, hyaluronic acid, 
platelet-rich plasma, or stem cells. Corticosteroid injections are supported for the 
management of knee OA (McAlindon et al., 2014; Hochberg et al., 2012), although a 
recent high quality randomized controlled trial suggests these injections are no better 
than placebo and may have damaging long-term effects to cartilage health (McAlindon 
et al., 2017).  A 2015 Cochrane Review found that corticosteroid injections may 
provide clinically important benefits, but are generally short-lived (Jüni et al., 2015).  
Viscosupplementation with hyaluronic acid injections is not currently recommended 
for the management of knee OA (McAlindon et al., 2014; Hochberg et al., 2012), as 
insufficient evidence exists to support their use (Bellamy, Campbell, Robinson, Gee, 
Bourne, & Wells, 2006).  
Platelet-rich plasma and stem cell injections have been more recently considered, but 
are not currently recommended in the management of knee OA.  A systematic review 
on the effectiveness of platelet-rich plasma found superior results compared to placebo 
and hyaluronic acid, but found that almost all included randomized controlled trials 
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had a high risk of bias (Laudy, Bakker, Rekers, & Moen, 2015).  While some 
randomized controlled trials have shown stem cell injections to be effective, a second 
systematic review reported all trials were at a high risk of bias, and as such, stem cell 
injections could not be recommended for the treatment of knee OA (Pas, Winters, 
Haisma, Koenis, Tol, & Moen, 2017).  
2.3.5 Surgery 
If patients do not achieve adequate symptomatic control through non-surgical 
management, surgical interventions are available for knee OA.  Three main types of 
surgery are used for knee OA: arthroscopic lavage and/or debridement, high tibial 
osteotomy, and total joint replacement. Arthroscopic surgeries are no longer 
recommended in surgical guidelines (Nelson et al., 2014; Richmond et al., 2013; 
Zhang et al., 2010) as many high quality randomized controlled trials have shown 
them to be ineffective (Moseley et al., 2002; Kirkly et al., 2008; Sihvonen et al., 
2013). A review of all available trials on arthroscopic procedures for knee OA found 
inconsequential benefits and an increased risk of harm (Thorlund, Juhl, Roos, & 
Lohmander, 2015).  As a result, arthroscopic procedures should not be used in the 
management of knee OA.  
A high tibial osteotomy may be used to correct malalignment in knee OA (Richmond 
et al., 2013; Zhang et al., 2010).  However, evidence supporting this procedure is 
limited and clinicians should use clinical judgment and patient preference when 
selecting this procedure.  In the absence of definitive recommendations for high tibial 
osteotomies, total joint replacement remains the main surgical intervention.  Joint 
replacement procedures are recommended for appropriate patients with knee OA 
(Nelson et al., 2014; McAlindon et al., 2014).  Joint replacement should only be 
performed after conservative options have been attempted with limited improvements 
in symptom control and functional gain (McAlindon et al., 2014).  
  
	  	   17 
2.4 Diagnosing Knee Osteoarthritis 
The diagnosis of knee OA is a much-debated topic and numerous case definitions have 
been used throughout the literature.  OA is currently considered a clinical diagnosis 
with imaging reserved for excluding differential diagnoses (Wenham, Grainger & 
Conaghan, 2014).  The American College of Rheumatology, National Institute for 
Health and Care Excellence and European League Against Rheumatism all support the 
diagnosis of knee OA based on clinical symptoms and examination findings (Altman, 
et al., 1986; National Institute for Health and Care Excellence, 2008; Zhang, et al., 
2010).  The only imaging guidelines for OA recommend that imaging is not required 
to make the diagnosis in patients with a typical presentation of OA (Sakellariou et al., 
2017).  These guidelines also note there is a lack of literature suggesting any 
additional value of imaging over clinical findings in making a diagnosis of OA 
(Sakellariou et al., 2017).  It has also been acknowledged that the diagnosis of knee 
OA can be made in the presence of specific clinical and examination features, even if 
radiographs appear normal (Zhang et al., 2010). 
2.4.1 Clinical Diagnosis for Knee OA 
Table 1 presents the most utilized diagnostic criteria for the diagnosis of knee OA, 
developed by the American College of Rheumatology (Altman et al., 1986).  They 
include assessment for crepitus, bony swelling, bony tenderness and lack of joint 
warmth.  However, their utility in general practice has been questioned (Cibere, 2006).  
Consequently, many clinical examination procedures have been developed for the 
assessment of knee OA.  The principle elements of the clinical examination for knee 
OA include alignment, bony swelling, crepitus, gait, inflammation, instability, muscle 
strength, tenderness and pain, and knee range of motion, all of which can be reliably 
assessed (Cibere et al, 2004).  
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Table 1  
American College of Rheumatology Diagnostic Criteria for Knee 
Osteoarthritis 
Category of Diagnostic 
Criteria 
Criteria 
 
Clinical 
 
Knee pain 
+ at least 3 of 6: 
- Age >50 years 
- Stiffness <30 minutes 
- Crepitus 
- Bony tenderness 
- Bony enlargement 
- No palpable warmth 
 
Clinical and 
Radiographic 
Knee pain + Osteophytes 
+ at least 1 of 3: 
- Age >50 years 
- Stiffness <30 minutes 
- Crepitus 
 
Clinical and  
Laboratory 
Knee pain 
+ at least 5 of 9: 
- Age >50 years 
- Stiffness <30 minutes 
- Crepitus 
- Bony tenderness 
- Bony enlargement 
- No palpable warmth 
- Erythrocyte sedimentation rate 
<40mm per hour 
- Rheumatoid factor <1:40 
- Synovial fluid signs of 
osteoarthritis 
 
Note. mm = millimeters, Adapted from Altman et al. (1986).	  
 
The European League Against Rheumatism OA Task Force recommends three 
symptoms: persistent knee pain, limited morning stiffness, and reduced function, and 
three signs: crepitus, restricted movement, and bony enlargement, as the most useful 
for diagnosing knee OA.  They suggest a diagnosis of knee OA can be made in adults 
over the age of 40 years with all three symptoms and at least one of the physical 
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examination signs (Zhang et al., 2010).  This diagnosis can be made without 
radiographs and applies even when radiographs appear normal (Zhang et al., 2010).  
Further analysis found that adults aged 45 years and older have a 99% probability of 
having radiographic knee OA when all six symptoms and signs are present (Zhang et 
al., 2010).  These recommendations are echoed in the National Institute for Health and 
Care Excellence guidelines (National Institute for Health and Care Excellence, 2014).  
These guidelines state that OA should be diagnosed clinically without investigations 
when a person is over 45 years of age and has activity-related joint pain with either no 
morning stiffness or morning stiffness lasting less than 30 minutes.  Currently, knee 
OA should be diagnosed clinically without need for further investigation or imaging in 
most cases.  However, the diagnostic accuracy of any such clinical examination is 
hindered by the lack of a consensus reference standard. 
2.4.2 Diagnostic Imaging for Knee OA 
Imaging examinations are commonly used to aid in OA diagnosis (Demehri, 
Guermazi, & Kwoh, 2016), but should be reserved for when an alternative diagnosis is 
being considered (Wenham, Grainger, and Conaghan, 2014).  Plain film radiographs 
are the recommended first line imaging modality for OA (Sakellariou et al., 2017) but 
they are insensitive to the early pathological changes of OA (Hunter & Guermazi, 
2012).  The lack of correlation between clinical symptoms and structural changes 
visualized on plain film radiographs is well documented (Bedson & Croft, 2008).  
Therefore, radiographic images have a limited role in the clinical assessment of OA 
(Peat, Croft & Hay, 2001).   Alternatively, magnetic resonance imaging (MRI) may be 
a more sensitive tool for the diagnosis of OA (Peterfy, 2002), as it is able to assess all 
the tissues involved in an osteoarthritic joint (Conaghan, 2006).  However, there is a 
lack of literature validating the use of MRI in the diagnosis of OA (Conaghan, 2006). 
As such, current imaging guidelines for the diagnosis of OA recommend that no 
imaging modality of any kind is required to make the diagnosis in patients with the 
typical presentation of OA (Sakellariou, et al., 2017).   
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2.4.3 Plain Film Radiography for Knee OA 
Plain film radiography is the imaging modality of choice in clinical practice (Demehri, 
Guermazi & Kwoh, 2016) and has historically been used as the primary technique to 
obtain a diagnosis of OA (Cibere, 2006; Peterfy, 2002).  A number of radiographic 
grading systems have been developed to diagnose OA. The most commonly used is 
the Kellgren-Lawrence grading, which uses a global score of 0-4 to grade the joint 
(Kellgren & Lawrence, 1957).  The Kellgren-Lawrence score is primarily based on the 
presence of osteophytes and joint space narrowing, which are associated with 
moderate to severe disease (Bedson & Croft, 2008).  A score of 2 or greater is the 
traditional cut-off point for a definitive diagnosis of OA.   
The American College of Rheumatology has also developed diagnostic criteria for 
knee OA that utilize plain film radiographs (Altman, et al., 1986).  Table 1 includes 
the radiographic criteria for knee OA.  However, these diagnostic criteria may not be 
applicable to general clinical practice, as they were developed using cases with more 
advanced disease than is likely to be encountered in the general population (Cibere, 
2006).  Moreover, the comparator group was made up of individuals with rheumatoid 
arthritis, and as a result, these criteria are better suited to differentiate OA from 
inflammatory joint conditions (Cibere, 2006).  
The use of radiography in the diagnosis of OA has a number of limitations.  X-rays are 
insensitive to the earliest pathological changes seen in OA (Hunter & Guermazi, 2012) 
and can appear normal in symptomatic joints (Guermazi, et al., 2012).  This is thought 
to be due to the fact that articular cartilage changes, which are not visualized on 
radiographs, are likely altered before bony changes are evident (Hunter et al., 2007; 
Peterfy, 2002).   This is compounded by the limitations of assessing a three-
dimensional joint using a two-dimensional radiographic image.  Osteophytes that are 
overlapped by adjacent bony features can remain undetected (Cibere, 2006).  One 
study suggests that plain film radiographs of the knee can only detect 60% of the 
osteophytes seen on MRI (Chan et al., 1991).    
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The discordance of clinical symptoms and structural changes visualized on plain film 
radiographs is well documented (Bedson & Croft, 2008; Chan et al., 1991; Hannan, 
Felson, & Pincus, 2000; Szebenyi et al., 2006; Toivanen et al., 2007).  As such, a 
review of the literature on radiographic imaging for OA concluded X-ray images have 
a limited role in the clinical assessment of OA (Peat, Croft & Hay, 2001).  Overall, the 
limited ability of radiography to detect OA features at an early stage of disease 
questions the utility of plain film radiographs as a diagnostic tool (Cibere, 2006).  As 
such, a reliance on plain film radiographs to diagnose OA is not recommended.  
2.4.4 Magnetic Resonance Imaging for Knee OA 
While only bone can be visualized on plain film radiographs, advanced imaging 
techniques, such as MRI have the ability to image all the tissues involved in an 
osteoarthritic joint (Conaghan, 2006). While MRI has an unparalleled ability to 
evaluate articular cartilage (Eckstein, Cicuttini, Raynauld, Waterton & Peterfy, 2006), 
it can also visualize ligaments, synovium, menisci and subchondral bone (Conaghan, 
2006).  As such, MRI is uniquely suited to assess the joint as a whole organ and may 
be a more sensitive tool for the diagnosis of OA (Peterfy, 2002).    
It has been shown that MRI is better able to detect osteophyte formation than plain 
films (Chan et al., 1991).  However, the potential utility of MRI in the diagnosis of OA 
may stem from whole-organ evaluation.  MRI has the ability to visualize bone marrow 
edema, which has been shown to be associated with painful knees (Conaghan, 2006).  
One study found in a sample of 400 individuals with radiographic knee OA that bone 
marrow edema was present in 78% of the painful knees but only in 30% of knees in 
the non-painful group (Felson et al., 2001).  It is also possible that OA symptomology 
may be attributed to synovitis, joint effusions, and meniscal and ligamentous 
pathology, but considerably less research exists evaluating these structures (Conaghan, 
Felson, Gold, Lohmander, Totterman & Altman, 2006).  
MRI-based metrics for whole-joint evaluation have gained attention in recent years 
(Hafezi-Nejad, Demehri, Guermazi & Carrino, 2018).  MRI-based quantitative and 
semi-quantitative scoring systems have been shown to provide reliable metrics for 
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evaluating structural morphology and damage (Hunter et al., 2011).  However, MRI 
does not currently have a place in routine clinical practice for diagnosing OA 
(Conaghan, 2006).  This is reflected in international imaging guidelines for OA, which 
state that should imaging be needed to exclude differential diagnoses, conventional 
radiography should be used before other modalities (Sakellariou et al., 2017).  This 
may be in part due to the fact that MRI abnormalities can be frequent even in those 
with normal knee radiographs (Taouli et al., 2002) and those without knee pain 
(Guermazi et al., 2012).  Additionally, MRI was shown to be of no benefit in 
diagnosing OA if clinical features were present prior to imaging (Petron et al., 2010).  
While MRI technologies have great potential to play a role in the diagnosis of OA, the 
current body of literature suggesting MRI may be useful for routine practice is limited 
(Conaghan, 2006). This relative lack of literature is likely related to the limited ability 
to modify the OA disease process, and thus limited application of advanced imaging 
techniques in the diagnosis of OA (Peterfy, 2002).  However, more studies are 
currently underway and further developments in MRI technology and image analysis 
tools hold promise for future disease evaluation (Conaghan, 2006; Conaghan, Felson, 
Gold, Lohmander, Totterman & Altman, 2006; Eckstein, Cicuttini, Raynauld, 
Waterton & Peterfy, 2006).  
2.4.5 Biomarkers for Knee OA 
Biochemical markers of osteoarthritic disease may facilitate earlier detection of knee 
OA (Abramson & Krasnokutsky, 2006, Bauer et al., 2006, Cibere et al., 2009).  The 
World Health Organization defines a biomarker as “any substance, structure, or 
process that can be measured in the body… and influences or predicts the incidence or 
outcome of disease” (Strimbu & Tavel, 2010).  Biomarkers can be indicators of 
pathogenic processes (De Grutolla et al., 2001) and are typically molecules or 
molecular fragments that are released as a result of joint tissue metabolism (Bauer et 
al., 2006).  Biomarkers for OA may come from multiple joint tissues, including 
synovial fluid, blood, urine, or connective tissue samples (Mobasheri & Henrotin, 
2015).  Identification of molecular abnormalities within joint tissues that precede 
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structural changes could allow for earlier detection of knee OA (Brandt, Doherty & 
Lohmander, 1998).  
Increased levels of various biomarkers have been found in individuals with OA 
(Cibere et al., 2009, Hunter et al., 2007).  In 2012, the OA Biomarkers Consortium 
selected twelve serum and/or urine biochemical markers to investigate (Hunter et al., 
2014).  Since that time, several novel biomarkers have been discovered (Watt, 2018).  
However, many of these biomarkers have not undergone the rigorous testing required 
to be considered diagnostic markers.  This is complicated by the lack of a gold 
standard definition for early OA that limits the ability of biomarkers to be evaluated in 
diagnostic studies (Watt, 2018).  Moreover, recent high quality studies have shown 
that biomarkers may lack the specificity needed to be of clinical utility (Watt, 2018).  
OA biomarkers are not localized to a specific joint and concentration levels can be 
influenced by age, sex, body composition, diet, various comorbidities, and drug 
interactions (Kraus, 2006).  While biomarkers are likely to play a role in the diagnosis 
of knee OA in the future, too little is currently understood to provide any meaningful 
contribution to the clinical or research setting at this time. 
2.5 Screening for Knee Osteoarthritis 
Screening for disease implies finding disease (Morrison, 1998) or risk factors 
(Fletcher, Fletcher & Fletcher, 2014) in asymptomatic individuals.  An effective 
screening test should be sensitive to early stages of a disease, when the subsequent 
course of the disease may still be altered (Fletcher, Fletcher & Fletcher, 2014).  The 
American College of Rheumatology criteria (Altman et al., 1986) were designed for 
advanced-stage knee OA and were not developed as epidemiological tools, although 
they are often used as such (Roux et al., 2008).  Many of the current methods for 
diagnosing knee OA are designed to identify late-stage disease (Jordan, Luta, Renner, 
Dragomir, Hochberg, & Fryer, 1997; O’Reilly, Muir, & Doherty, 1996), and thus are 
not ideal for screening.  It is well known that there are issues with case identification 
in the study of knee OA epidemiology (Spector & Hochberg, 1994).  Historically, 
radiographs have been used to screen for knee OA, but they are expensive and expose 
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patients to potentially harmful radiation (LaValley, McAlindon, Evans, Chaisson, & 
Felson, 2001).  Staged-screening approaches, such as patient self-report of symptoms 
followed by radiography or physical examination, have been suggested (Cooper, 
McAlindon, Coggon, Egger & Dieppe, 1994; O’Reilly, Muir & Doherty, 1998; 
Hopman-Rock, Odding, Hofman, Kraaimaat & Bijlsma, 1997; March, Schwarz, 
Carfrae & Bagge, 1998; Oliveria, Felson, Klein, Reed & Walker, 1996), but still 
require costly radiographs and/or clinical evaluation.   
Patient self-report of symptoms may be a cheaper alternative to more costly screening 
strategies.  Various symptom questions to predict the presence of knee OA have been 
studied, but these focus on individual questions rather than on development of a 
screening instrument (March, Schwarz, Carfrae & Bagge, 1998; O’Reilly, Muir & 
Doherty, 1996).   However, it has been argued that no single symptom can identify 
patients with knee OA (Corti & Rigon, 2003).  Moreover, it remains unknown if 
multi-item questionnaires can predict symptomatic knee OA without need for 
additional, more costly evaluations (LaValley et al., 2001).   
The goal of a screening questionnaire is to select a group of people in whom further 
investigations will yield a high rate of OA diagnoses, known as high specificity, 
without missing a substantial number of patients with OA, known as high sensitivity 
(Roux, et al. 2008).  Previous attempts have been made to create screening instruments 
for knee OA (LaValley et al., 2001; Quintana et al., 2007; Roux et al., 2008; Marra et 
al., 2007).   However, these instruments were largely based on current diagnostic 
criteria and their diagnostic testing is limited.    
Three screening instruments created by LaValley and colleagues were developed 
through analysis of questionnaire responses from 1921 participants in the Framingham 
OA Study (LaValley et al., 2001).  Their intent was first to create an instrument that 
maximized sensitivity, then a second instrument that maximized specificity, and 
finally a third instrument to provide a balance of both sensitivity and specificity.  
However, when each instrument was tested against the reference standard of clinical 
examination and knee radiographs in a validation sample, none of the instruments 
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displayed adequate diagnostic test performance.  As such, they concluded that all three 
instruments resulted in too much misclassification to be used as a single-step screening 
process (LaValley et al., 2001).  
The next attempt at developing a screening tool for knee OA was undertaken in Spain 
in 2007 (Quintana et al., 2007).  Quintana and colleagues developed the Knee and Hip 
Osteoarthritis Screening Questionnaire that used questions specific to knee OA, 
questions specific to hip OA, and shared questions for both hip and knee OA 
(Quintana et al., 2007).  When compared to the reference standard of examination by 
an orthopedic surgeon, including knee radiographs, the knee questionnaire was found 
to have a sensitivity of 94.5%, but a poor specificity of only 43.2%.  Moreover, only 
44% of individuals identified by the questionnaire underwent the reference standard 
examination, raising questions about the validity of the results.  In addition, only 
individuals over the age of 60 were sampled, which may limit the ability of the knee 
questionnaire to detect disease in younger individuals at an earlier stage.  As a result, 
the authors suggest that screening for knee OA in the general population still requires 
individuals to self-report knee symptoms and then be followed up with a clinical 
examination (Quintana et al., 2007).   
In 2008, a questionnaire to identify knee OA was developed in France to be 
administered over the telephone (Roux et al., 2008).  When tested against the reference 
standard of clinical evaluation and radiographic evidence, the instrument displayed 
high sensitivity and specificity.  The validation sample also included individuals as 
young as 45 years, which means this instrument may have utility in populations of 
individuals with early disease.  However, less than 23% of the 479 participants who 
were identified by the questionnaire underwent reference standard testing, questioning 
the internal validity of the study results.  Therefore, the authors concluded that 
telephone administration of screening instruments is feasible (Roux et al., 2008), but 
the low participation rate limited any conclusions regarding the effectiveness of the 
questionnaire utilized.   
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A Canadian study evaluated the effectiveness of a screening questionnaire for knee 
OA administered by pharmacists (Marra et al., 2007).  Pharmacists administered the 
questionnaire to 411 participants, of which 274 screened positively.  Only 70% of 
these individuals received the reference standard of clinical examination and 
radiographs and it was found that the questionnaire could correctly identify over 80% 
of individuals with undiagnosed knee OA, but considerable bias may exist.  The 
authors concluded that pharmacists could play an important role in the identification of 
undiagnosed knee OA and that much of this OA is in the early stages and likely most 
amenable to intervention (Marra et al., 2007).  However, only participants who 
screened positively on the questionnaire received the reference testing, and thus, no 
calculation of sensitivity or specificity was possible.  This is problematic, as it is not 
known how many subjects excluded by the questionnaire truly had knee OA, known as 
false negatives.  At minimum, this questionnaire requires further testing in a more 
rigorous diagnostic study before it can be used as a screening instrument for knee OA.   
These previous attempts at developing a multi-item questionnaire to screen for knee 
OA (LaValley et al., 2001; Quintana et al., 2007; Roux et al., 2008; Marra et al., 2007) 
illustrate the potential of this relatively inexpensive strategy.  Unfortunately, the 
previously developed tools may not be sensitive to early stage knee OA, as they were 
developed using current diagnostic criteria and were not adequately tested in patient 
samples likely to suffer from early disease.  Furthermore, several methodological 
flaws, such as lack of patient perspective in questionnaire item generation, low 
participation rates in validation procedures, and weak diagnostic study design limit our 
understanding of the utility of these screening instruments.   Most notably, not one 
study included a “period of time for follow-up” in which the disease may be allowed 
to develop in individuals who initially tested negative (Fletcher, Fletcher & Fletcher, 
2014).   
However, the diagnostic performance of the previously created instruments suggests 
there is potential that a screening questionnaire could be developed that will 
adequately classify individuals as having knee OA or not.  As such, a new screening 
instrument that does not rely on late-stage disease criteria should be developed and 
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tested in rigorous diagnostic studies.  With proper identification of early-stage knee 
OA, treatments that can alter the disease course, such as exercise and weight-loss 
programs can be tested and implemented earlier in the disease process.  There is a 
clear need to develop a single-step screening instrument that is able to detect early-
stage knee OA.   
2.6 Illness Behaviour 
Knee OA is a chronic disease where individuals often adapt their behaviours to 
manage symptoms and disability (Gignac, Cott, & Badley, 2002).  Through interviews 
with 248 individuals with OA, it was found that almost all people make at least one 
adaptation and that most make multiple adaptations (Gignac, Cott, & Badley, 2002).  
Analysis revealed that these adaptations were largely motivated by real and perceived 
changes or losses in function, providing evidence that patient perceptions may play a 
more significant role in mediating behavioural changes than presumed (Gignac, Cott, 
& Badley, 2002).  There is a psychosocial context in which individuals with chronic 
knee pain/OA make decisions about their health and need for care.  Further knowledge 
of this process may result in earlier identification of knee OA and better care for these 
individuals.  
Many theoretical models have been developed in the behavioural and social sciences 
of how individuals appraise and respond to health conditions (Baltes & Baltes, 1990; 
Diefenbach & Leventhal, 1996; Mechanic, 1986).  Three main models of illness 
contribute to our understanding of illness perception and behaviour in individuals with 
chronic knee pain/OA. The first is the model of selective optimization with 
compensation, which describes general adaptation processes across a spectrum of 
illnesses (Baltes & Baltes, 1990). It has three components describing adaptation: 
selection or restriction of certain activities, optimization of functional capacity, and 
compensation or modifying behaviours to perform certain activities (Baltes & Baltes, 
1990). 
Gignac et al., (2002) used the model of selective optimization with compensation to 
conceptualize the adaptation process to disability for individuals with OA.  Of 248 
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participants interviewed, most reported using all three types of adaptation from the 
model.  However, it is difficult to differentiate between selection, optimization, and 
compensation, as these components were found to be interrelated (Gignac, Cott, & 
Badley, 2002).  The findings of this work provide evidence that an individual’s 
perceptions play a role in facilitating the adaptation behaviours to disability from OA, 
but this model does not explain the cognitive processes that drive behaviour (Gignac, 
Cott, & Badley, 2002). 
Second is the common-sense model of illness representation, or Leventhal’s self-
regulatory model of illness behaviour (Diefenbach & Leventhal, 1996; Leventhal, 
Meyer, & Nerenz, 1980).  This theoretical framework attends to both internal and 
external sources of information to create illness representations (Diefenbach & 
Leventhal, 1996).  This model positions the individual as an active problem solver 
based on both cognitive and emotional psychological processes that are ignored by the 
biomedical model (Diefenbach & Leventhal, 1996; Leventhal, 1970).  
Meta-analysis of studies using the common-sense model of illness representation has 
shown that an individual’s thoughts about their illness are moderate-to-strongly related 
to coping behaviours (Orbell & Hagger, 2003). These findings illustrate a consistency 
in the way in which individuals cognitively represent illness in a range of health 
conditions (Orbell & Hagger, 2003).  There is however, no empirical evidence 
supporting the validity or utility of the common-sense model in individuals with 
chronic knee pain/OA. 
Third is Mechanic’s model of illness behaviour, which posits that symptoms may be 
perceived, evaluated, and acted upon differently by individuals (Mechanic, 1986; 
Mechanic & Volkart, 1960).  This model predicts large variability in reactions to 
symptoms and illness, as it is the necessary link between biomedicine and behavioural 
science (Mechanic & Volkart, 1960; Mechanic, 1995).  The model of illness behaviour 
represents the interaction of bodily dysfunction with both a psychological and 
sociocultural context, identifying four domains of illness that explain the decision-
making process.  The first is monitoring of one’s body and symptoms, followed by 
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defining and interpreting symptoms.  Third is remedial actions taken by the individual, 
and lastly is utilization of help from various sources (Mechanic, 1986; Mechanic, 
1995).  These four phases make up the socially defined state, which informs the 
decision-making process and need not be associated with an altered biological state 
(Febrega, 1973).   
Mechanic argued that this illness behaviour model may be more efficient than the 
diagnostic disease model in addressing the burden of illness and disability (Mechanic, 
1995).  The disease model does not take into account variability in behavioural 
responses among individuals with the same disease (Sirri, Fava, & Sonino, 2013).   
Sirri et al., (2013) argue that illness behaviour can explain the “major prognostic 
differences among deceptively similar patients” and thus, may provide an improved 
alternative to the biomedical disease model for illness recognition and medical care for 
patients, including those with chronic knee pain/OA.  
Sirri et al., (2013) posit that illness behaviour is a unifying construct for perceptions, 
care-seeking behaviour, treatment adherence, and delay in seeking treatment.  Many 
instruments have been developed in an attempt to operationalize features of the illness 
behaviour construct.  Many of these patient self-rated scales provide measurements of 
subjective views of their illness behaviour (Sirri, Flava, & Sonino, 2013).  Prior and 
Bond (2013) recommended that any measure of illness behaviour include both covert, 
such as cognitive and emotional processes, as well as overt or observable behaviours.  
Pilowsky (1969) operationalized abnormal illness behaviour based on Mechanic’s 
definition through the creation of the Illness Behaviour Questionnaire.  The Illness 
Behaviour Questionnaire was original developed as a 62-item measure consisting of 
seven different subscales (Pilowsky, 1969). However, there is much debate over the 
true number of scales and factor structure of the Illness Behaviour Questionnaire, as 
subsequent factor analysis supported a three-scale model (Prior & Bond, 2010).  
Furthermore, little is known about the applicability of this measure outside of the 
chronic pain and psychiatric populations (Prior & Bond, 2013).  Most importantly, 
Prior and Bond (2013) argue that the Illness Behaviour Questionnaire lacks items that 
directly tap any overt characteristics of illness behaviour.  
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There have been many other attempts at the operationalization of components of the 
illness behaviour construct (Prior & Bond 2013; Hamilton et al., 2017).  For example, 
the Fear Avoidance Beliefs Questionnaire (Waddell, Newton, Henderson, Somerville, 
& Main, 1993), Coping Strategies Inventory (Carver, Scheier, & Weintraub, 1989), 
Knee Osteoarthritis Fears and Beliefs Questionnaire (Benhamou et al., 2013), and the 
Arthritis Self-Efficacy Scale (Lorig, Chastain, Ung, Shoor, & Holman, 1989), among 
others, have all been created to measure components of illness behaviour.  However, 
all of these measures lack items that tap at least one domain from Mechanic’s model 
of illness behaviour and/or have not been validated in a population with chronic knee 
pain/OA (Hamilton et al., 2017).  The only measure with some evidence of validity in 
this population that specifically addresses all domains of Mechanic’s model of illness 
behaviour is the Questionnaire to Identify Knee Symptoms (Hamilton et al., 2017). 
2.7 QuIKS Questionnaire 
Stemming from the potential utility of a measure able to quantify illness behaviour in 
individuals with chronic knee pain consistent with OA, a series of studies were 
undertaken to develop such a tool.  The first study by Maly and Cott (2009) aimed to 
identify the process individuals use to recognize and address chronic knee problems 
that could be precursors to knee OA, as they hypothesized that patient experience 
could provide an ideal method to screen for individuals with pre-diagnostic knee OA 
(Maly & Cott, 2009).   A grounded theory methodology was utilized to identify a 
theoretical model of this process. Twenty-six individuals at varying stages of 
experiencing a chronic knee problem were identified, of which ten individuals had a 
recent knee OA diagnosis and sixteen individuals had no formal diagnosis.  A model 
(Figure 1) was developed from the themes identified through axial coding and constant 
comparative analysis of the interview transcripts.  
  
	  	   31 
 
 
Figure 1. Model of the process of recognizing the onset of chronic knee problems. Reprinted from 
“Being careful: a grounded theory of emergent chronic knee problems”, by M. Maly and C. Cott, 2009, 
Arthritis Care and Research, 61(7), p.939. Copyright 2009 by John Wiley and Sons (Appendix 1).  
 
The process of recognizing and addressing begins with a stage of becoming aware of 
chronic knee symptoms.  This stage is characterized by the admittance and acceptance 
of a chronic knee problem by the individual, typically associated with increased 
frequency and consistency of the knee symptoms.  A major determinant of this stage is 
the acknowledgment of difficulty participating in physical activities due to the impact 
of the knee symptoms (Maly & Cott, 2009).  
Their findings further suggested that after becoming aware of the chronic knee 
symptoms, the individual enters a cyclical process of interpreting the symptoms and 
being careful during physical activity.  Interpreting refers to attempts made by the 
individual to understand the meaning and significance of their knee symptoms.  Of 
note, the authors found that these interpretations were influenced by social and 
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cognitive contextual factors, as many participants reported that interactions with 
others, such as friends, co-workers, and health care practitioners, along with personal 
experiences and memories from family members with chronic musculoskeletal 
symptoms, informed their decision-making process (Maly & Cott, 2009). 
The second part of the cyclical process, being careful, was defined by the investigators 
as the perceptions, intentions, and behaviours of the individual used to avoid potential 
harms while engaging in physical activities.  At this stage, individuals typically have 
the cognitive perception of diminished physical ability, leading to intentions and 
behaviours to perform physical activities with greater care.  Three main actions were 
identified that compose being careful: 1) monitoring, where attention is given to 
factors that trigger knee symptoms; 2) modifying, where numerous strategies are 
employed to adjust physical activities in response to symptoms and to protect the 
knee; and 3) planning, where intentions to maintain physical activity despite knee 
symptoms are formed, through the use of anticipatory strategies to prevent harm, such 
as exercise. The authors describe the process of being careful during daily activities as 
a cognitive and behavioural approach to self-management of chronic knee symptoms, 
even before a formal diagnosis of knee OA is made (Maly & Cott, 2009). 
The investigators found that the cyclical process of interpreting and being careful 
continues until the occurrence of an event that signals the inadequacies of this self-
management strategy, termed as the interfering stage in the model.  The interviews 
revealed that this interfering event always involved the inability to carry out a task of 
significant personal value, such as sport or a leisure activity, which caused the 
individual to seek more formal care for their knee complaint, termed accessing care.  
The authors posited that the individual’s interpretation of important daily activities is 
the key criterion for the signal to access care for chronic knee problems in this study 
population (Maly & Cott, 2009).  
There are many social, cognitive, and behavioural elements to the model proposed by 
Maly and Cott (2009), sharing many components with Mechanic’s model of illness 
behaviour (Mechanic, 1986).  The authors of this model suggested that aspects of the 
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model, particularly being careful, could be used as a way of identifying pre-diagnostic 
knee OA prior to these individuals seeking care and formal diagnosis.  While no tool 
existed to quantify the being careful construct, the Arthritis Self-Efficacy Scale (Lorig, 
Chastain, Ung, Shoor, & Holman, 1989) may capture elements of being careful, but a 
specifically designed tool is likely required to detect pre-diagnostic knee OA 
experiences (Maly & Cott, 2009).  
Using the process model identified by Maly and Cott (2009), a multi-phase research 
project was designed to develop an instrument capable of identifying emerging knee 
problems, ultimately named the Questionnaire to Identify Knee Symptoms (QuIKS) 
(Appendix 2) (Clark, Chesworth, Speechley, Petrella, & Maly, 2014).  The aim was to 
develop a self-administered questionnaire for clinical and research settings, as all 
diagnostic procedures for knee OA available at that time identified advanced disease 
only.   
In the first phase of the project, item development, individual questionnaire items to 
cover Maly and Cott’s (2009) model of recognizing and addressing emerging knee 
problems were generated (Clark, Chesworth, Speechley, Petrella, & Maly, 2014).  
Maly and Cott’s (2009) transcripts of the participant interviews were reviewed to 
identify a list of experiences for each of the four stages of their model: interpreting 
knee symptoms, monitoring knee pain, modifying activities in response to knee 
problems, and planning for the future.  Potential questionnaire items were then 
generated to represent each of these experiences, resulting in a total of 33 potential 
items (Clark, Chesworth, Speechley, Petrella, & Maly, 2014).  A 5-point rating scale 
was chosen to quantify these experiences and behaviours, where some items assessed 
agreement using a Likert scale from “strongly disagree” (0) to “strongly agree” (4), 
while others assessed frequency using an adjectival scale from “never” (0) to “always” 
(4)  (Streiner, Norman, & Cairney, 2015).  The developers also chose to frame the 
questions with a two-week time window, as it has been reported that individuals with 
knee OA requiring arthroscopic surgery can adequately recall their health status over 
this time period (Bryant, Norman, Stratford, Marx, Walter, & Guyatt, 2006).  
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In the second phase of tool development, expert review, a 16-member panel of 
Canadian OA experts reviewed the 33 generated items and response scales.  The 
review panel included rheumatologists, orthopedic surgeons, family practitioners, 
physical therapists and health care researchers with expertise in OA and measurement 
scale development and validation.  Recommendations on clinical utility, scaling, 
ambiguous and inappropriate items, and additional constructs to consider were 
developed by this panel.  The expert recommendations were used to inform the 
drafting of a 35-item questionnaire, organized into three sections: medications and 
treatments, activities, and living with knee problems (Clark, Chesworth, Speechley, 
Petrella, & Maly, 2014).  Although not specifically stated by the developers of the 
measure, this phase provides evidence of content validity of the QuIKS (Streiner, 
Norman, & Cairney, 2015).  
In the third phase of the QuIKS development, item reduction, principal components 
analysis informed the selection of only items that explain a high proportion of the test 
score variance for the final questionnaire. Participants were recruited from an Ontario 
family medicine clinic through medical chart review. Patients with evidence of knee 
pain lasting longer than two weeks, with no diagnosis of knee OA or any other 
condition that explained their symptoms were invited to complete the preliminary 35-
item QuIKS questionnaire. Data from 105 completed questionnaires was used in the 
principle component analysis.  The final solution resulted in a 13-item questionnaire, 
composed of four subscales, named: medications, monitoring, interpreting, and 
modifying (Clark, Chesworth, Speechley, Petrella, & Maly, 2014).  These subscales 
were scored individually, as this best captured each individual respondent (Clark, 
Chesworth, Speechley, Petrella, & Maly, 2014). 
A secondary objective of the project was to assess the internal consistency reliability 
of the final QuIKS subscales (Clark, Chesworth, Speechley, Petrella, & Maly, 2014).  
Internal consistency reliability of each subscale was assessed using Cronbach’s alpha 
(Cronbach, 1951). The medication subscale with three items demonstrated an alpha of 
0.82, the monitoring subscale with three items 0.83, the interpreting subscale with four 
items 0.73, and the modifying subscale with three items 0.87.  
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Through this three-phase development process, a short, self-administered instrument, 
named the QuIKS, was created with the aim of identifying individuals at increased risk 
of developing or in the early stages of knee OA (Clark, Chesworth, Speechley, 
Petrella, & Maly, 2014). This instrument, while primarily designed as a research tool, 
may also have utility in the clinical setting with limited burden to patients, an 
important property emphasized during expert review.  Furthermore, evidence was 
provided through the QuIKS development process of content validity (from the expert 
panel) and internal consistency reliability from a sample of individuals with early knee 
symptoms.  However, the developers recommend that these results be confirmed in an 
independent sample, as estimates of these properties tend to be overly optimistic when 
they are derived from development samples (MacCallum, Wideman, Zhang, & Hong, 
1999).  Moreover, the authors recommended that future research assess the predictive 
validity of the QuIKS, but note that this may prove difficult as the lack of criterion 
standard may limit the design (Clark, Chesworth, Speechley, Petrella, & Maly, 2014). 
Hamilton et al., (2017) performed a systematic review of measures capturing 
components of Mechanic’s model of illness behaviour (Mechanic, 1986). Utilizing a 
systematic methodological framework for scoping reviews, they found sixteen 
different measures used in 71 studies demonstrating at least content validity in a 
sample of individuals with knee pain or OA.  Each measure captured at least one 
component of Mechanic’s definition of illness behaviour, but only one measure, the 
QuIKS, captured all four components of illness behaviour (Hamilton, Wong, Gignac, 
Davis, & Chesworth, 2017).   
Most of the measures identified captured only one or two of the components of illness 
behaviour, as they were originally conceptualized to quantify constructs such as 
coping strategies, self-efficacy, and fear avoidance behaviours (Hamilton, Wong, 
Gignac, Davis, & Chesworth, 2017). Therefore, the QuIKS is the most comprehensive 
measure providing complete coverage of illness behaviours experienced by an 
individual with emergent chronic knee symptoms. While the work by Clark et al. 
(2014) provides evidence of content validity, other forms of validity, such as construct 
or criterion validity have not been addressed (Hamilton, Wong, Gignac, Davis, & 
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Chesworth, 2017; Streiner, Norman, & Cairney, 2015).  Hamilton and colleagues 
recommended that the QuIKS undergo further studies of its validity to determine 
whether its psychometric properties are sound (Hamilton, Wong, Gignac, Davis, & 
Chesworth, 2017).   
Hamilton and colleagues also performed a study to investigate the validity of the 
QuIKS in individuals with chronic knee problems, such as OA (Hamilton et al., 2015).  
With no criterion measure available for illness perception and behaviour, criterion 
validity could not be tested (Clark, Chesworth, Speechley, Petrella, & Maly, 2014; 
Streiner, Norman, & Cairney, 2015).  Therefore, investigations of the validity of the 
QuIKS need to focus on construct validity (Streiner, Norman, & Cairney, 2015).  
Hamilton et al., (2015) used two objectives to evaluate the construct validity of the 
QuIKS measure.  The primary objective was to use Rasch analysis to determine if the 
QuIKS captures a unidimensional construct, as combining the subscales of the QuIKS 
into a single measure may reflect the higher-order construct of illness behaviour 
(Hamilton et al., 2015).  Rasch validation has been argued as a form of construct 
validity in itself (Velozo, Seel, Magasi, Heinemann, & Romero, 2012).  The secondary 
objective was to test the known-groups validity and convergent validity of the Rasch-
validated QuIKS (QuIKS-R) (Hamilton et al., 2015).    
Fifty-five individuals with healthy knees, 111 individuals with chronic knee pain but 
no OA diagnosis, and 34 patients with diagnosed knee OA awaiting surgery were 
enrolled for a total of 200 participants.  Rasch analysis of the QuIKS measure revealed 
an adequate fit to a unidimensional model, providing evidence of construct validity of 
the QuIKS-R (Appendix 2).  Analysis also required the response structure to be altered 
to conform with the Rasch model, such that the original 5-point scale (scored 0 to 4) 
be converted to a 0 to 2 scale with the original middle three response categories (1, 2, 
and 3) all scored as 1. As such, the QuIKS-R (the Rasch version of the QuIKS) can be 
used to provide interval-level scoring for the unidimensional construct of illness 
behaviour.  
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As per the secondary objective, mean QuIKS-R scores from each of the three enrolled 
groups were used to compare the three known-groups to determine whether there was 
evidence of construct validity.  The a priori hypothesis was the distribution of QuIKS-
R scores should vary by group with the highest scores in the pre-surgical group and 
lowest scores in the subjects with healthy knees.  Total scores on the QuIKS-R were 
found to be significantly different between all three known-groups in the hypothesized 
directions, with moderate effect sizes.  As hypothesized a priori, the healthy knee 
group exhibited significantly less illness perceptions and behaviours than the chronic 
knee pain group, who in turn exhibited significantly less illness perceptions and 
behaviours than the pre-surgical group.  These findings support the construct validity 
of the QuIKS-R in a sample of individuals with chronic knee symptoms.  
To complete the secondary objective, the total QuIKS-R scores were correlated with 
the five subscales (pain, symptoms, function in daily living, function in sport and 
recreation, and knee-related quality of life) of the Knee injury and Osteoarthritis 
Outcome Score (KOOS) to evaluate the convergent validity.  As predicted, total 
QuIKS-R scores had significant moderate correlations with scores on the KOOS 
subscales.  Spearman correlation coefficients ranged from 0.45 to 0.77, supporting the 
construct validity of the QuIKS-R in a population of individuals with chronic knee 
symptoms.  
While evidence of construct validity for the QuIKS-R was shown through its 
measurement of a unidimensional construct, as well as through its hypothesized ability 
to discriminate between known-groups and correlations with other measures of related 
constructs, the results must be viewed with hesitation.  These tests involved participant 
data used to develop the QuIKS-R measure, and therefore, may represent an overly 
optimistic picture of its construct validity (MacCallum, Wideman, Zhang, & Hong, 
1999).  It has been recommended that the QuIKS-R undergo investigation of construct 
validity using a larger sample that is independent from the development sample 
(Hamilton et al., 2015). 
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2.8 Construct Validity 
Construct validity, originally described by Cronbach and Meehl (1955), is a 
framework used to interpret a measure of a latent trait that is not directly observable or 
measurable.  This framework is utilized when no criterion standard is accepted as 
entirely adequate to measure the quality (Cronbach & Meehl, 1955).  Measures of 
unobservable psychological phenomena, which can be valuable to explaining human 
behaviour, can be validated using these principles (Smith, 2005). The validation of 
these phenomena, or constructs, is demonstrated through predictable relationships 
derived from theoretical hypotheses between a measure of a particular construct and 
other measures of similar constructs (Kirshner & Guyatt, 1985; Cronbach & Meehl, 
1955; Nunnally, 1978; Carmines & Zeller, 1979).   
Smith (2005) has proposed a model for construct validation.  The first requirement for 
construct validation is the specification of the construct in question. This requires 
explicit definition of the construct under investigation.  Once defined, the construct 
must undergo translation into informative hypotheses that can be tested.  Based on the 
hypothesis generated, specification of the appropriate research design can be made. 
Following data collection, an explanation of how the observations pertain to 
predictions must be formulated.  Based on the relationship between the observations 
and predicted outcomes, revision of theory and construct can be performed.  It is 
through this framework that a construct can be evaluated and shown to have validity.   
The key feature of the model prosed by Smith (2005) is the focus on testing of 
specified hypotheses.  Subscribing to the notion that construct validity can be assessed 
through a number of potential hypotheses (Lawshe, 1985; Landy, 1985; Streiner, 
Norman, & Cairney, 2015), the researcher is able to generate different methods and 
validation analyses.  The notion of validation as a framework of hypothesis testing and 
analysis dictates that no one research design or statistic defines construct validity 
(Streiner, Norman, & Cairney, 2015), and as such, various types of analysis can be 
used to demonstrate construct validity (Lawshe, 1985).   
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Two commonly utilized construct validation methods are convergent validation and 
discriminative validation (Cronbach & Meehl, 1955; Campbell & Fiske, 1959; 
Streiner, Norman, & Cairney, 2015).  Convergent validation attempts to hypothesize 
and quantify how closely a measurement scale of the theoretical construct is related to 
other constructs and measures (Cronbach & Meehl, 1955; Kirshner & Guyatt, 1985; 
Streiner, Norman, & Cairney, 2015).  Simply stated, two measures of similar 
constructs should be hypothesized to show similar scores. Conversely, two measures 
of unrelated constructs should show less similar scores.  As such, convergent 
validation typically utilizes a correlation analysis of data collected at a single time-
point (Kirshner & Guyatt, 1985; Streiner, Norman, & Cairney, 2015).  The correlation 
statistic selected depends on the nature and properties of the measurement scales under 
investigation (Bonett & Wright, 2000; Streiner, Norman, & Cairney, 2015).  
While there is no specific correlation value at which a measure can be said to exhibit 
convergent validity, it has been suggested that a moderate Pearson coefficient value of 
0.5 or greater is supportive (Guyatt, Norman, Juniper, & Griffith, 2002).  However, a 
correlation value between two measurement scales that is too high (greater than 0.9) 
suggests that both scales are measuring the same construct, and thus, are redundant 
and unneeded (Streiner, Norman, & Cairney, 2015). Therefore, moderate to strong 
correlational values observed in convergent validation designs can be considered to 
support construct validity.   
The second commonly utilized test of construct validity is known as discriminative 
validation.  Discriminative validation is used to distinguish between predictably 
different individuals or groups (Streiner, Norman, & Cairney, 2015).  This 
methodology requires the formulation of a hypothesis about which known-groups of 
people will have higher or lower amounts of the construct under investigation, 
observed via scores on the measurement index (Cronbach & Meehl, 1955; Kirshner & 
Guyatt, 1985; Streiner, Norman, & Cairney, 2015). For example, a group of 
individuals with severe knee OA may be hypothesized to have higher pain level scores 
than individuals known to have mild knee OA.   
	  	   40 
As discriminative validation involves testing the predicted differences between 
known-groups of individuals, statistical analysis typically involves tests of the mean 
difference.  A between groups t-test or ANOVA can be considered for discriminative 
validation analyses. While no specific magnitude of mean difference, or effect size, is 
required to show discriminative validity, one would expect differences of at least 
moderate effect size between observably-distinct groups (Cohen, 1988).   
The validation procedures of a construct and measurement scale must be designed and 
conducted using rigorous scientific methods.  Quality criteria have been proposed to 
ensure the internal validity of the inferences made from these study designs (Terwee et 
al., 2007, Mokkink et al., 2010).  A convergent validation design requires that 
expected correlational magnitude and direction be hypothesized prior to data 
collection and analysis (Terwee et al., 2007). Similarly, a discriminative validation 
design requires that the predicted magnitude and direction of the differences between 
known-groups be stated a priori (Terwee et al., 2007).  Tools such as the Consensus-
based Standards for the selection of health status Measurement Instruments 
(COSMIN) Checklist can be used to ensure the methodological quality when 
designing a construct validity study (Mokkink et al., 2010).  However, these quality 
criteria were derived from expert opinion, as there is no empirical evidence to suggest 
that certain correlational or mean difference values must be attained to support 
construct validity (Terwee et al., 2007).  Even Cronbach and Meehl (1955), predicted 
that a single “construct validity coefficient” was unlikely to be developed, due to the 
approximate nature of the validation process.  
2.9 Internal Consistency Reliability 
In addition to validity, a measurement scale should demonstrate reliability (Carmines 
& Zeller, 1979).  Reliability of a scale is “the extent to which measurements are 
repeatable and that any random influence which make measurements different from 
occasion to occasion is a source of measurement error” (Nunnally, 1967).  Simply 
stated, reliability is the ratio of the variance of true scores (or subject variability) to the 
variance of total scores (or total variability) (Streiner, 2003; Streiner, Norman, & 
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Cairney, 2015; Winer, 1971; Guilferd, 1965).  The total variability of a scale can be 
broken down into the variability attributed to the items, subjects, and raters (Cortina, 
1993).  
One of the most widely utilized estimates of reliability is coefficient alpha (Cortina, 
1993; Streiner, 2003).  Coefficient alpha, or Cronbach’s alpha or α, is a measure of the 
internal consistency of a scale and is mathematically equivalent to the mean of all 
split-half correlations (Cronbach, 1951). This method for estimating reliability has the 
practical advantage of requiring only a single administration of the measurement scale, 
as compared to other methods, which require multiple test administrations or multiple 
raters (Streiner, 2003; Streiner, Norman, & Cairney, 2015).   
Coefficient alpha was originally touted as an estimate of the lower limit of reliability, 
as it was thought that test-retest or interrater reliability would produce higher values 
(Lord & Novick, 1968; Cortina, 1993).  However, coefficient alpha may actually be an 
estimate of the upper bound of reliability, depending on the properties of the 
measurement scale.  Simply stated, if a measurement scale is comprised of items that 
all measure one construct and use the same number of response options, the scale can 
be said to be tau-equivalent or parallel (Streiner, Norman, & Cairney, 2015).  Under 
these circumstances, coefficient alpha is an estimate of the upper limit of reliability 
(Falk & Savalei, 2011).   
Assuming that the internal consistency of a tau-equivalent or parallel scale is under 
investigation, one must determine an acceptable coefficient alpha value.  There are 
many published recommendations for acceptable values (Ponterotto & Ruckdeschel, 
2007).  Nunnally (1967) originally recommended a value of 0.50 to 0.60 for scales in 
the early stages of research, but later revised these values to 0.70 (Nunnally, 1978; 
Nunnally & Bernstein, 1994).  A value of 0.80 for basic research tools and 0.90 for 
clinical tools was also recommended (Nunnally, 1967).  Carmines and Zeller (1979) 
also supported the use of 0.80 for research tools.  However, Streiner (2003) argues that 
a coefficient value over 0.90 likely indicates redundancy in the items, and thus should 
be viewed as the upper limit for measurement scales.  
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It is important to note that the internal consistency of a scale, as measured by 
coefficient alpha, is highly sensitive to changes in the number of items in the measure 
(Cortina, 1993; Streiner, 2003).  The coefficient alpha will increase simply as a 
function of the increasing number of items, so long as the additional items are equally 
good measures of the construct.  As such, some authors argue that the acceptable 
coefficient value is dependent on the number of items in the scale and the study 
sample size.  For example, Ponterotto and Ruckdeschel (2007) state that for 
measurement scales with 12 or more items, tested on less than 100 subjects, requires 
an internal consistency coefficient of 0.70 to be considered fair and 0.85 to be 
considered excellent.   
In general, a coefficient alpha value of 0.80 can be considered an adequate estimate of 
the lower bound of reliability for measurement scales used in basic research (Nunnally 
& Bernstein, 1994; Streiner, 2003).  The original four-subscale version of the QuIKS 
measure was shown to have internal consistency reliabilities from 0.73 to 0.87 (Clark, 
Chesworth, Speechley, Petrella, & Maly, 2014).  However, these coefficient values 
were calculated in the same sample of individuals used to create the scale and since 
that time, the QuIKS has been revised into a unidimensional measure (Hamilton et al., 
2015).  Therefore, the latest version of the QuIKS requires evaluation of the internal 
consistency reliability in an independent test sample.   
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Chapter 3 
3 Methods 
3.1 Design 
This was a cross-sectional study where participants recruited from physical therapy 
clinics across Canada completed a package of self-report health questionnaires at a 
single point in time.  The questionnaire package also contained a detailed letter of 
information (Appendix 3) and consent form (Appendix 4), as well as a participant 
characteristics form to collect demographic and illness-related data on each 
participant.  Participant eligibility was further verified with a self-report inclusion and 
exclusion criteria checklist. 
Included in the questionnaire package were six self-report health questionnaires: 1) 
Brief Pain Inventory – Short Form (BPI), 2) Questionnaire to Identify Knee Symptoms 
(QuIKS), 3) European Quality of Life 5 Dimensions (EQ-5D-5L), 4) Medical 
Outcomes Study Short Form 12 Survey - version 2(SF-12v2), 5) Physical Activity 
Scale for the Elderly (PASE), and 6) Knee Osteoarthritis and Injury Outcome Score 
Physical Function Short Form (KOOS-PS).  
Ethics approval was granted by Western University’s Health Sciences Research Ethics 
Board (#106206) (Appendix 5).  Each participant provided written informed consent.   
3.2 Participants 
Participants were recruited from select physical therapy clinics across Canada 
according to study eligibility criteria.  Physical therapist collaborators from selected 
clinics identified potential participants for eligibility and provided initial information 
about the study and a postcard to send to the investigators indicating their interest in 
participating.  The study coordinator mailed interested participants a questionnaire 
package at the time of receipt of the postcard requesting further information.  Data 
were collected from April 2016 to June 2018.   
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To qualify for the study, participants must have fulfilled the following inclusion 
criteria: 1) fluency in the English language, 2) between the ages of 40-79 years, 3) 
have had pain, aching, or discomfort in or around the knee during the past 12 months, 
and 4) have had knee pain on most days of the month at any time in the past.   
Participants with any of the following criteria were excluded: 1) diagnosed with a 
neurological problem, 2) diagnosed with chronic obstructive pulmonary disease, 3) 
diagnosed with rheumatoid arthritis or ankylosing spondylitis, 4) diagnosed with 
fibromyalgia, 5) diagnosed with lupus, 6) diagnosed with gout, 7) have had chronic 
back, hip, or foot pain, 8) have a history of acute knee injury within the last 6 months, 
9) have had or are scheduled for a total knee replacement, 10) have had a high tibial 
osteotomy, 11) have a terminal condition, or 12) are missing a leg.  These inclusion 
and exclusion criteria helped to ensure that the knee pain and illness perceptions and 
behaviours of the subjects would be consistent with knee OA. 
3.3 Measures 
Sample descriptive data included sex, age, height and weight to calculate body mass 
index, as well as data regarding the affected knee (unilateral or bilateral), history of 
previous knee injury, history of formal diagnosis of knee OA, and time period of knee 
symptoms. 
QuIKS 
The QuIKS was designed to be a discriminative measure to quantify illness behaviour 
in knee pain consistent with knee OA (Clark, Chesworth, Speechley, Petrella, & Maly, 
2014; Hamilton et al., 2015).   It is the only measure shown to capture all components 
of illness behaviour identified in people with knee pain and knee OA (Hamilton, 
Wong, Gignac, Davis, & Chesworth, 2017).   
The QuIKS is a 13-item self-administered questionnaire, with each item having a 5-
point rating scale. The monitoring, interpreting, and modifying portions of the QuIKS 
use Likert responses from strongly disagree (0) to strongly agree (2), while the 3-item 
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medication portion use adjectival responses from never (0) to always (2).  When the 
total raw score is converted to the final score, scores of the QuIKS range from 0 to 100 
(worst to best state). 
The original version of the QuIKS has been shown to have adequate measurement 
reliability (Clark, Chesworth, Speechley, Petrella, & Maly, 2014), while the Rasch 
validated version of the QuIKS was shown to be unidimensional and have interval-
level measurement properties (Hamilton et al., 2015).  Preliminary evidence of 
construct validity of the 13-item Rasch-validated QuIKS was also found across a range 
of individuals with knee symptoms consistent with knee OA that provided the data 
used to develop the QuIKS (Hamilton et al., 2015).   
KOOS-PS 
The Knee injury and Osteoarthritis Outcome Score Physical Function Short Form 
(KOOS-PS) is a 7-item self-administered questionnaire, used to assess an individual’s 
difficulty with physical function due to problems with their knee (Perruccio et al., 
2008).  The KOOS-PS has interval-level measurement properties with scores ranging 
from 0 to 100 (no difficulty to extreme difficulty) (Perruccio et al., 2008).  The 
KOOS-PS has strong internal consistency reliability and construct validity in knee OA 
populations (Perruccio et al., 2008; Davis et al., 2009; Collins, Prinsen, Christensen, 
Bartels, Terwee, & Roos, 2016).  Moreover, the KOOS-PS instrument is 
recommended as a measure of knee function for patients with osteoarthritis (Rolfson et 
al., 2016). 
BPI 
The Brief Pain Inventory (BPI) is a 9-item self-administered questionnaire, used to 
assess pain in a number of chronic pain conditions (Poquet & Lin, 2016).  The BPI has 
two subscales: Pain Severity and Pain Interference.  The pain severity score consists of 
the sum of 4 items about pain intensity, with cumulative scores ranging from 0 to 40 
(no pain to worst pain).  The pain interference scale is the total of 7 sub-items, with 
scores ranging from 0 to 70 (no interference to complete interference) (Poquet & Lin, 
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2016).  The BPI has ordinal-level measurement properties.  The BPI has been shown 
to be a reliable instrument for assessing chronic pain, with good test-retest reliability 
and internal consistency (Pelayo-Alvarez, Perez-Hoyos, & Agra-Varela, 2013; Wu, 
Beaton, Smith, & Hagan, 2010; Tittle, McMillan, & Hagan, 2003).  The BPI has also 
been shown to have good construct and criterion validity (Gjeilo, Stenseth, Wahba, 
Lydersen, & Klepstad, 2007; Tan, Jensen, Thornby, & Shanti, 2004). 
SF-12v2 
The Medical Outcomes Study Short Form 12 Survey - version 2 (SF-12v2) is a subset 
scale of the SF-36 health related quality of life measure.  It is a 12-item measure with 
two component scores, the Physical Component Summary Score (PCS) and the Mental 
Component Summary Score (MCS) (Ware, Kosinski, Turner-Bowker, & Gandek, 
2002).  These component scores represent the underlying construct of perceived 
physical and mental health, respectively. Both the PCS and MCS have scores that 
range from 0 (worst health) to 100 (best health).  The SF-12v2 has been shown to have 
adequate reliability and validity in a number of musculoskeletal conditions, including 
rheumatoid arthritis, spinal disorders, and other health-related conditions (Linde et al., 
2009; Lee, Browell, & Jones, 2008; Sutton & Raines, 2010; Sloan, Sawada, Martin, 
Church, & Blair, 2009). The SF-12 instrument is recommended as a measure of 
health-related quality of life for patients with knee OA (Rolfson et al., 2016). 
EQ-5D VAS 
The EuroQOL Five Dimensions questionnaire (EQ-5D) is a measure of health status 
developed by the EuroQol Group (EuroQol Group, 1990).  The EQ-5D instrument is 
recommended as a measure of health-related quality of life for patients with knee OA 
(Rolfson et al., 2016). The EQ-5D has two sections. First is a descriptive section 
measuring mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression.  The second is the EQ Visual Analogue Scale (EQ-5D VAS), 
which measures an individual’s self-rated health from 0 (worst imaginable health 
state) to 100 (best imaginable health state).  The most recent version, used in this 
study, includes 5 response levels for each dimension of the descriptive section, and is 
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thus called the EQ-5D-5L (Herdman et al., 2011).  The introduction of 5 response 
levels to the EQ-5D has been shown to increase reliability and validity (Brooks, 1996).  
However, the response levels have no arithmetic properties and only provide a 
descriptive code for the individual (van Reenen & Janssen, 2015).  As such, only data 
from the EQ-5D VAS was used in this study. 
PASE 
The Physical Activity Scale for the Elderly (PASE) is designed to measure self-
reported physical activity levels in older adults (Washburn, Smith, Jette, & Janney, 
1993).  The PASE includes questions on household, leisure time, and work-related 
activities, which are assigned a value corresponding to light, moderate, or strenuous 
levels of intensity.  The frequencies of these activities are also recorded as never (0 
days/ week), seldom (1-2 days/week), sometimes (3-4 days/week), or often (5-7 
days/week). The frequency of each activity is multiplied by its intensity to determine 
an overall physical activity level score.  The PASE has been shown to be a valid and 
reliable measure of physical activity in the community-dwelling elderly and in 
sedentary older adult populations (Washburn, Smith, Jette, & Janney, 1993; 
Washburn, McAuley, Katula, Mihalko, & Boileau, 1999).  
3.4 Data Analysis 
3.4.1 Sample Characteristics 
Descriptive characteristics were summarized for the entire sample.  All data analyses 
were performed with SPSS version 24.0 (SPSS Inc, Chicago, Illinois).   
3.4.2 Objective 1: Construct Validation 
Objective 1A. Convergent Validation 
The QuIKS measure was assessed for convergent validity with each of the self-report 
measures completed by the study participants. Statistical analysis utilized a correlation 
procedure, dependent on the measurement properties of the scale being correlated to 
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the QuIKS measure, as well as the satisfaction of the underlying assumptions of the 
specified statistical procedure.  Confidence intervals for correlation coefficients, r and 
rs, were constructed using Fisher’s z transformation: z = !! log! !!!!!! with standard error, SE! = !!!!.  A 95% confidence limit was constructed using z± 1.96 ∗ SE!.  These 
confidence limits were then back transformed to provide intervals for the correlation 
coefficients (Norman & Streiner, 2008).  Seven a priori hypotheses were made, each 
specifying the expected direction and magnitude of the correlation.  The seven 
hypotheses are presented in order from strongest to weakest anticipated correlation.  
Final decisions on the evidence from each test to support the convergent validity were 
based on the satisfaction of the a priori hypotheses, taking into account both the 
magnitude and direction of the relationship.  A moderate correlation of at least 0.5 was 
considered to be supportive of convergent validity (Guyatt, Norman, Juniper, & 
Griffith, 2002).  Any questionnaires with missing values were excluded from the 
analysis.    
QuIKS & KOOS-PS 
It was hypothesized that a strong negative correlation would be observed between 
scores on the QuIKS and KOOS-PS. This hypothesis was based on the reasoning that 
a measure of people’s opinions about the difficulties they experience with activity due 
to problems with their knee should be substantially related to a measure that quantifies 
an individual’s knee illness perception and behaviour.  As a lower QuIKS score 
indicates increased illness perception and behaviour, while a higher KOOS-PS score 
indicates increased difficulty with physical function, a negative correlation was 
expected.  Pearson’s product-moment correlation coefficient (r) was used to quantify 
this relationship, as both scales have interval-level properties. This analysis required 
an estimated sample size of 49 subjects, calculated using an r of -0.7 (95% CI = -0.85, 
-0.55) at an alpha value of 0.05 (Bonett & Wright, 2000).  
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QuIKS & BPI Pain Interference  
It was hypothesized that a strong negative correlation would be observed between 
scores on the QuIKS and Pain Interference subscale of the BPI. This hypothesis was 
based on the reasoning that a measure of pain interference during an individual’s daily 
life should be substantially related to a measure that quantifies an individual’s knee 
illness perception and behaviour. As a lower QuIKS score indicates increased illness 
perception and behaviour, while a higher BPI Pain Interference score indicates 
increased pain interference, a negative correlation was expected.  Spearman’s rank 
correlation coefficient (rs) was used to quantify this relationship, as the BPI Pain 
Interference scale has ordinal-level properties.  This analysis required an estimated 
sample size of 60 subjects, calculated using an rs of -0.7 (95% CI = -0.85, -0.55) at an 
alpha value of 0.05 (Bonett & Wright, 2000).  
QuIKS & BPI Pain Severity 
It was hypothesized that a moderate negative correlation would be observed between 
scores on the QuIKS and Pain Severity subscale of the BPI. This hypothesis was based 
on the reasoning that a measure of an individual’s knee pain severity should be 
substantially related to a measure that quantifies an individual’s knee illness 
perception and behaviour.  As a lower QuIKS score indicates increased illness 
perception and behaviour, while a higher BPI Pain Severity score indicates increased 
pain levels, a negative correlation was expected.  Spearman’s rank correlation 
coefficient (rs) was used to quantify this relationship, as the BPI Pain Severity scale 
has ordinal-level properties.  This analysis required an estimated sample size of 86 
subjects, calculated using an rs of -0.6 (95% CI = -0.75, -0.45) at an alpha value of 
0.05 (Bonett & Wright, 2000).  
QuIKS & SF-12v2 PCS 
It was hypothesized that a moderate positive correlation would be observed between 
scores on the QuIKS and the Physical Component Summary (PCS) of the SF-12v2.  
This hypothesis was based on the reasoning that a measure of an individual’s physical 
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health should be substantially related to a measure that quantifies an individual’s knee 
illness perception and behaviour.  As a higher QuIKS score indicates decreased illness 
perception and behaviour, while a higher PCS score indicates a higher level of 
physical health, a positive correlation was expected. Pearson’s product-moment 
correlation coefficient (r) was used to quantify this relationship.  This analysis 
required an estimated sample size of 74 subjects, calculated using an r of 0.6 (95% CI 
= 0.45, 0.75) at an alpha value of 0.05 (Bonett & Wright, 2000).  
QuIKS & EQ-5D VAS 
It was hypothesized that a moderate positive correlation would be observed between 
scores on the QuIKS and EQ VAS. This hypothesis was based on the reasoning that a 
measure of an individual’s health status should be substantially related to a measure 
that quantifies an individual’s knee illness perception and behaviour.  As a higher 
QuIKS score indicates decreased illness perception and behaviour, while a higher EQ 
VAS score indicates better health status, a positive correlation was expected.  
Pearson’s product-moment correlation coefficient (r) was used to quantify this 
relationship, as both scales have interval-level properties.  This analysis required an 
estimated sample size of 74 subjects, calculated using an r of 0.6 (95% CI = 0.45, 
0.75) at an alpha value of 0.05 (Bonett & Wright, 2000).  
QuIKS & PASE 
It was hypothesized that a moderate positive correlation would be observed between 
scores on the QuIKS and PASE. This hypothesis was based on the reasoning that a 
measure of an individual’s physical activity should be substantially related to a 
measure that quantifies an individual’s knee illness perception and behaviour.  As a 
higher QuIKS score indicates decreased illness perception and behaviour, while a 
higher PASE score indicates greater physical activity levels, a positive correlation was 
expected. Spearman’s rank correlation coefficient (rs) was used to quantify this 
relationship, as the PASE scale has ordinal-level properties.  This analysis required an 
estimated sample size of 111 subjects, calculated using an rs of 0.5 (95% CI = 0.35, 
0.65) at an alpha value of 0.05 (Bonett & Wright, 2000). 
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QuIKS & SF-12v2 MCS 
It was hypothesized that a moderate positive correlation would be observed between 
scores on the QuIKS and the Mental Component Summary (MCS) of the SF-12v2.  
This hypothesis was based on the reasoning that a measure of an individual’s mental 
health should be substantially related to a measure that quantifies an individual’s knee 
illness perception and behaviour.  As a higher QuIKS score indicates decreased illness 
perception and behaviour, while a higher MCS score indicates a higher level of mental 
health, a positive correlation is expected.  Pearson’s product-moment correlation 
coefficient (r) was used to quantify this relationship.  This analysis required an 
estimated sample size of 99 subjects, calculated using an r of 0.5 (95% CI = 0.35, 
0.65) at an alpha value of 0.05 (Bonett & Wright, 2000).  
Objective 1B. Discriminative Validation 
The QuIKS measure was assessed for discriminative validity by identifying known-
groups from the collected demographic characteristics, as well as the self-report health 
questionnaires.  Statistical analyses compared group mean QuIKS scores, dependent 
on the number of groups being compared and the satisfaction of the underlying 
assumptions of the specified statistical procedure.  Any questionnaires with missing 
values were excluded from the analysis.  Eight a priori hypotheses were made, each 
specifying the expected magnitude of the difference between the known-groups.  Final 
decisions on the evidence from each test to support the discriminative validity were 
based on the satisfaction of the a priori hypotheses, taking into account both the 
magnitude of the effect size between groups and the direction of mean differences 
between the known-groups.  The eight a priori hypotheses are presented in order of 
strongest to weakest hypothesized effect size.  
Previous Diagnosis of Knee OA vs. No Diagnosis of Knee OA 
It was hypothesized that the total scores from the QuIKS would be significantly higher 
for the known-group with no diagnosis than for the known-group with a previous knee 
OA diagnosis, with at least a moderate effect size.  This hypothesis was based on the 
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premise that individuals with a formal diagnosis of knee OA are likely to have more 
advanced disease and therefore exhibit greater levels of illness perception and 
behaviour.  An independent samples t-test was used to compare the mean QuIKS 
scores between the groups.  A Cohen’s d of 0.8 is considered a large effect size 
(Cohen, 1988). To detect the anticipated effect size (Cohen’s d = 0.8), the required 
sample size would be 27 subjects per group with an alpha value of 0.05 and a power of 
0.80 (Kastenbaum, Hoel, & Bowman, 1970).  
Groups of High, Medium, and Low Physical Function 
Distribution-based cut points were used to form three tertiles in the KOOS-PS data, 
resulting in three groups of high, medium, and low physical function.  It was 
hypothesized that the total scores from the QuIKS would be significantly higher for 
the high physical function group versus the medium physical function group, and 
higher for the medium physical function group versus the low physical function group, 
with a large effect size.  It was expected that individuals with lower KOOS-PS scores, 
and therefore higher physical function, would display less illness perception and 
behaviour, and thus higher QuIKS scores.  One-way analysis of variance was used.  A 
Cohen’s f of 0.8 is considered a large effect size (Cohen, 1988).  To detect the 
anticipated effect size (Cohen’s f = 0.8), the required sample size would be 30 subjects 
per group at an alpha value of 0.05 and a power of 0.8 (Kastenbaum, Hoel, & 
Bowman, 1970).   
Groups of High, Medium, and Low Pain Interference 
Distribution-based cut points were used to form three tertiles in the BPI Pain 
Interference data, resulting in three groups of high, medium, and low pain interference.  
It was hypothesized that the total scores from the QuIKS would be significantly higher 
for the low pain interference group versus the medium pain interference group, and 
higher for the medium pain interference group versus the high pain interference group, 
with a strong effect size.  It was expected that individuals with increasing levels of 
pain interference in their daily activities, thus higher BPI Pain Interference scores, 
would exhibit greater illness perception and behaviour and therefore lower QuIKS 
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scores.  One-way analysis of variance was used.  A Cohen’s f of 0.8 is considered a 
large effect size (Cohen, 1988). To detect the anticipated effect size (Cohen’s f = 0.8), 
the required sample size would be 30 subjects per group at an alpha value of 0.05 and 
a power of 0.8 (Kastenbaum, Hoel, & Bowman, 1970).  
Groups of High, Medium, and Low Pain Severity 
Distribution-based cut points were used to form three tertiles in the BPI Pain Severity 
data, resulting in three groups of high, medium, and low pain severity.  It was 
hypothesized that the total scores from the QuIKS would be significantly higher for 
the low pain severity group versus the medium pain severity group, and higher for the 
medium pain severity group versus the high pain severity group, with a moderate 
effect size.  It was expected that individuals with increasing levels of pain severity in 
their lives, thus higher BPI Pain Severity scores, would exhibit greater illness 
perception and behaviour and therefore lower QuIKS scores.  One-way analysis of 
variance was used.  A Cohen’s f of 0.7 is considered a moderate effect size (Cohen, 
1988). To detect the anticipated effect size (Cohen’s f = 0.7), the required sample size 
would be 40 subjects per group at an alpha value of 0.05 and a power of 0.8 
(Kastenbaum, Hoel, & Bowman, 1970). 
Groups of High, Medium, and Low Physical Health  
Distribution-based cut points were used to form three tertiles in the SF-12v2 PCS data, 
resulting in three groups of high, medium, and low physical health.  It was 
hypothesized that the total scores from the QuIKS would be significantly higher for 
the high physical health group versus the medium physical health group, and higher 
for the medium physical health group versus the low physical health group, with a 
moderate effect size.  It was expected that individuals with increasing levels of 
physical health, thus higher PCS scores, would display less illness perception and 
behaviour and therefore higher QuIKS scores.  The nonparametric equivalent of the 
one-way analysis of variance (Kruskall-Wallis test) was used.  A Cohen’s f of 0.7 is 
considered a moderate effect size (Cohen, 1988). To detect the anticipated effect size 
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(Cohen’s f = 0.7), the required sample size would be 40 subjects per group at an alpha 
value of 0.05 and a power of 0.8 (Kastenbaum, Hoel, & Bowman, 1970).  
Groups of High, Medium, and Low Health Status 
Distribution-based cut points were used to form three tertiles in the EQ-5D VAS data, 
resulting in three groups of high, medium, and low health status.  It was hypothesized 
that the total scores from the QuIKS would be significantly higher for the high health 
status group versus the medium health status group, and higher for the medium health 
status group versus the low health status group, with a moderate effect size.  It was 
expected that individuals with increasing health status, thus higher EQ VAS scores, 
would display less illness perception and behaviour and therefore higher QuIKS 
scores.  One-way analysis of variance was used.  A Cohen’s f of 0.7 is considered a 
moderate effect size (Cohen, 1988). To detect the anticipated effect size (Cohen’s f = 
0.7), the required sample size would be 40 subjects per group at an alpha value of 0.05 
and a power of 0.8 (Kastenbaum, Hoel, & Bowman, 1970).  
Groups of High, Medium, and Low Physical Activity 
Distribution-based cut points were used to form three tertiles in the PASE data, 
resulting in three groups of high, medium, and low physical activity.  It was 
hypothesized that the total scores from the QuIKS would be significantly higher for 
the high physical activity group versus the medium physical activity group, and higher 
for the medium physical activity group versus the low physical activity group, with a 
moderate effect size.  It was expected that individuals with increasing levels of 
physical activity, thus higher PASE scores, would display less illness perception and 
behaviour and therefore higher QuIKS scores.  One-way analysis of variance was 
used.  A Cohen’s f of 0.6 is considered a moderate effect size (Cohen, 1988). To detect 
the anticipated effect size (Cohen’s f = 0.6), the required sample size would be 50 
subjects per group at an alpha value of 0.05 and a power of 0.8 (Kastenbaum, Hoel, & 
Bowman, 1970).  
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Groups of High, Medium, and Low Mental Health 
Distribution-based cut points were used to form three tertiles in the SF-12v2 MCS 
data, resulting in three groups of high, medium, and low mental health.  It was 
hypothesized that the total scores from the QuIKS would be significantly higher for 
the high mental health group versus the medium mental health group, and higher for 
the medium mental health group versus the low mental health group, with a moderate 
effect size.  It was expected that individuals with increasing levels of mental health, 
thus higher MCS scores, would display less illness perception and behaviour and 
therefore higher QuIKS scores.  One-way analysis of variance was used.  A Cohen’s f 
of 0.6 is considered a moderate effect size (Cohen, 1988). To detect the anticipated 
effect size (Cohen’s f = 0.6), the required sample size would be 50 subjects per group 
at an alpha value of 0.05 and a power of 0.8 (Kastenbaum, Hoel, & Bowman, 1970). 
3.4.3 Objective 2: Internal Consistency Reliability 
The QuIKS measure was assessed for internal consistency reliability using Cronbach’s 
alpha (Cronbach, 1951).  A high value of alpha implies that the QuIKS is measuring a 
single construct (Carmines & Zeller, 1979).  An alpha value ≥ 0.8 is adequate to 
provide evidence for instrument reliability for basic research tools (Nunnally & 
Bernstein, 1994; Streiner, 2003).  The estimated required sample size was 80 subjects 
for the 13-item QuIKS measure, to achieve a 95% confidence interval of width 0.2 for 
Cronbach’s alpha of 0.8 (95% CI = 0.7, 0.9) (Bonett, 2002).   
3.4.4 Sample Size Requirement 
A total sample of 150 subjects with knee pain and symptoms consistent with knee OA 
was calculated to be required to adequately assess all construct validity and internal 
consistency reliability hypotheses.   
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Chapter 4 
4 Results 
4.1 Response Rate 
The collaborating physiotherapists identified 105 potentially eligible participants and 
mailed a postcard to the research team, indicating their interest in taking part in the 
study.  Flow diagram of participant enrollment in the study is shown in Figure 2. Of 
the 105 questionnaire packages mailed by the research team, 23 (21.9%) of the 
participants were deemed ineligible due to eligibility criteria.  Fifty-five of the 
potential 82 participants consented to participate and returned the questionnaire 
package.  With 82 eligible participants as the denominator and 55 completed 
questionnaires, the response rate was calculated to be 67.1%.  Of the 55 returned 
questionnaires, four individuals did not complete the QuIKS measure, excluding them 
from the final analysis.  
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Figure 2. Flow diagram of participant enrollment in study. 
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4.2 Sample Characteristics 
Table 2 presents the demographic characteristics of the 51 respondents with useable 
data.  Fifty-three percent of respondents were women and the average age of the 
sample was 60.3 ± 10.0 years.  The average BMI for the sample was 27.7 ± 6.8 kg/m2, 
indicating participants in the study on average, were overweight.  Forty-seven percent 
of the respondents reported suffering from unilateral knee symptoms and 51% 
reported suffering from bilateral knee symptoms, while one individual did not indicate 
whether they had unilateral or bilateral knee complaints. Over 37% of the respondents 
reported a previous knee injury and over 41% reported having received a formal knee 
OA diagnosis. 	  
Table 2 
Sample Characteristics 
Characteristic 
 
Mean Standard deviation 
Age, years 60.3 10.0 
BMI, kg/m2 27.7 6.8 
   
Characteristic 
 
n % 
Sex, Female 27 52.9 
Affected Knee(s)   
Unilateral 24 47.0 
Bilateral 26 51.0 
Missing 1 2.0 
History of Knee Injury, Yes 19 37.3 
Previous Knee OA Diagnosis, Yes 
 
21 41.2 
Note. BMI= Body mass index.   
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4.3 Objective 1: Construct Validation 
Objective 1A. Convergent Validation 
The a priori hypothesized correlation coefficient magnitudes were not observed for relationships between 
the QuIKS and hypothesized related constructs of the KOOS-PS, BPI pain interference, BPI pain 
severity, and SF-12v2 PCS measures, although for each of these, statistically significant moderate 
correlations of magnitudes from 0.4 to 0.6 were found.  The a priori hypothesized correlation magnitudes 
were not observed on comparisons of QuIKS scores with EQ-5D VAS, PASE, and SF-12v2 MCS 
scores.  A statistically significant, but weak correlation was found with the EQ-5D VAS.  No significant 
correlations were observed with the PASE and SF-12v2 MCS scores.  Correlation values and 95% 
confidence intervals are listed in Table 3 and scatter plots for each comparison can be found in Figure 3.  
Table 3 
Convergent Validity Results 
Comparator 
Measure 
 
 
Hypothesis Correlation 
Statistic 
95% 
Confidence 
Interval 
n Match  
Hypothesis 
     Magnitude Direction 
 
KOOS-PS 
 
r = -0.70 r = -0.46 -0.66, -0.20 48 No Yes 
BPI Pain 
Interference 
 
rs = -0.70 rs = -0.57 -0.74, -0.34 46 No Yes 
BPI Pain 
Severity 
 
rs = -0.60 rs = -0.44 -0.65, -0.17 46 No Yes 
SF-12v2 PCS 
 
r = 0.60 r = 0.56 0.33, 0.73 49 No Yes 
EQ-5D VAS 
 
r = 0.60 r = 0.30 0.02, 0.53 50 No Yes 
PASE 
 
rs = -0.50 rs = -0.13 -0.41, 0.17 44 No Yes 
SF-12v2 MCS r = 0.50 r = -0.04 -0.32, 0.24 49 No No 
 
Note. KOOS-PS= Knee injury and Osteoarthritis Outcome Score Physical Function Short Form, BPI= Brief Pain 
Inventory, SF-12v2 PCS= Medical Outcomes Study Short Form 12 Survey - version 2 Physical Component Summary, 
EQ-5D VAS= EuroQOL Five Dimensions Visual Analogue Scale, PASE= Physical Activity Scale for the Elderly, SF-
12v2 MCS= Medical Outcomes Study Short Form 12 Survey - version 2 Mental Component Summary, r= Pearson 
correlation coefficient, rs= Spearman correlation coefficient.  
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Figure 3. Scatter plot of Questionnaire to Identify Knee Symptoms total score and other health measures score (one for each 
test of convergent validity). QuIKS= Questionnaire to Identify Knee Symptoms, KOOS-PS= Knee injury and Osteoarthritis 
Outcome Score Physical Function Short Form, BPI= Brief Pain Inventory, SF-12v2 PCS= Medical Outcomes Study Short 
Form 12 Survey - version 2 Physical Component Score, EQ-5D VAS= EuroQOL Five Dimensions Visual Analogue Scale, 
PASE= Physical Activity Scale for the Elderly, SF-12v2 MCS= Medical Outcomes Study Short Form 12 Survey - version 2 
Mental Component Summary. 
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Figure 3 continued. Scatter plots of Questionnaire to Identify Knee Symptoms total score and other 
health measures score (one for each test of convergent validity). QuIKS= Questionnaire to Identify Knee 
Symptoms, KOOS-PS= Knee injury and Osteoarthritis Outcome Score Physical Function Short Form, 
BPI= Brief Pain Inventory, SF-12v2 PCS= Medical Outcomes Study Short Form 12 Survey - version 2 
Physical Component Score, EQ-5D VAS= EuroQOL Five Dimensions Visual Analogue Scale, PASE= 
Physical Activity Scale for the Elderly, SF-12v2 MCS= Medical Outcomes Study Short Form 12 Survey - 
version 2 Mental Component Score. 	  
Objective 1B. Discriminative Validation 
The independent samples t-test revealed that the total scores on the QuIKS were significantly different 
among individuals with a previous diagnosis of knee OA when compared to those without a previous 
diagnosis.  The one-way ANOVA (or Kruskal-Wallis H test) revealed that a priori hypotheses were not 
met for the QuIKS ability to discriminate between known-groups of physical function, pain interference, 
pain severity, and physical health, as measured by the KOOS-PS, BPI pain interference, BPI pain 
severity, and SF-12v2 PCS measures.  However, moderate effect sizes were observed in the 
hypothesized direction.  Statistically significant mean differences were found between at least two of the 
groups in these analyses.  This relationship is evident in the corresponding box plots (Figure 4) where the 
gradient in distribution between groups is in the anticipated direction.  Non-significant group differences 
indicated that the QuIKS was unable to discriminate between known-groups of health status, physical 
activity, and mental health, as defined by the EQ-5D VAS, PASE, and SF-12v2 MCS, respectively.  This 
finding is illustrated in the corresponding box plot (Figure 4), where no gradient between groups is 
visualized.  Effect sizes can be found in Table 4 and box plots for each analysis in Figure 4.   
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Table 4  
Discriminative Validity Results 
Known-group 
(Measure) 
 
Hypothesized 
Effect Size 
Effect 
Size 
n Test 
Statistic 
p Match  
Hypothesis 
 
      Magnitude Direction 
 
Diagnosed 
Knee OA 
 
d = 0.80 d = 0.70 50 t = 2.45 0.02 No Yes 
Physical 
Function 
(KOOS-PS) 
 
f = 0.80 f = 0.62 48 F = 10.27 <0.001 No Yes 
Pain 
Interference 
(BPI) 
 
f = 0.80 f = 0.69 46 F = 11.29 <0.001 No Yes 
Pain Severity 
(BPI) 
 
f = 0.70 f = 0.46 46 F = 5.31 0.009 No Yes 
Physical 
Health 
(SF-12v2 
PCS) 
 
f = 0.70 f =0.63 49 H = 13.31 0.001 No Yes 
Health Status 
(EQ-5D VAS) 
 
f = 0.70 f = 0.09 50 F = 0.26 0.77 No No 
Physical 
Activity 
(PASE) 
 
f = 0.60 f = 0.16 44 F = 0.42 0.66 No No 
Mental Health 
(SF-12v2 
MCS) 
 
f = 0.60 f = 0.19 49 F = 0.89 0.42 No No 
 
Note. OA= osteoarthritis, KOOS-PS= Knee injury and Osteoarthritis Outcome Score Physical Function Short Form, 
BPI= Brief Pain Inventory, SF-12v2 PCS= Medical Outcomes Study Short Form 12 Survey - version 2 Physical 
Component Summary, EQ-5D VAS= EuroQOL Five Dimensions Visual Analogue Scale, PASE= Physical Activity 
Scale for the Elderly, SF-12v2 MCS= Medical Outcomes Study Short Form 12 Survey - version 2 Mental Component 
Summary, d= Cohen’s d, f= Cohen’s f, t= independent samples t-test statistic, F= one way analysis of variance test 
statistic, H= Kruskal-Wallis test statistic. 
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Figure 4. Box plots of mean Questionnaire to Identify Knee Symptoms scores for each known group (one for each test of 
discriminative validity). QuIKS= Questionnaire to Identify Knee Symptoms, OA= osteoarthritis.  
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Figure 4 continued. Box plots of mean Questionnaire to Identify Knee Symptoms scores for each 
known group (one for each test of discriminative validity). QuIKS= Questionnaire to Identify Knee 
Symptoms.  	  
4.4 Objective 2: Internal Consistency Reliability 
The second objective was to assess the internal consistency reliability of the QuIKS. The internal 
consistency reliability was found to be 0.81, which meets the minimum value for acceptable reliability 
(Streiner, Norman, & Cairney, 2015). No items were missing in the calculation of the internal 
consistency reliability.  
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Chapter 5 
5 Discussion 
5.1 Overview of Results 
The primary objective of this study was to evaluate the construct validity of the QuIKS measurement 
tool in a sample of individuals with chronic knee symptoms consistent with OA.  This was the first 
evaluation of the construct validity of the QuIKS in an independent sample.  The construct validity of the 
QuIKS was evaluated using tests of both convergent and discriminative validity. In total, 15 a priori 
hypotheses were tested.  However, none of the pre-specified hypotheses were met.  Despite the findings 
not affirming the a priori hypotheses, the majority of data does appear to support the construct validity of 
the QuIKS, as many of the findings met the recommended thresholds for construct validity (Guyatt, 
Norman, Juniper, & Griffith, 2002; Terwee et al., 2007).  The secondary objective was to evaluate the 
internal consistency reliability in an independent sample.  The QuIKS appears to have adequate internal 
consistency reliability, as the Cronbach’s alpha for the scale was 0.81.  Overall, the findings of this study 
support the construct validity and internal consistency reliability of the QuIKS.  
5.2 Convergent Validity 
Seven convergent validity hypotheses were generated a priori.  The findings of this study indicate that 
the QuIKS may be a valid measure, as the total scores were moderately correlated with the KOOS-PS, 
BPI Pain Interference, BPI Pain Severity, and SF-12v2 PCS scales.  While these findings did not meet 
the a priori hypotheses, there were moderate correlations in the hypothesized direction for these 
comparisons, and moderate correlation values have been suggested to support convergent validity of a 
measure (Guyatt, Norman, Juniper, & Griffith, 2002).  Therefore, illness behaviour appears to be a 
higher order construct that incorporates an individual’s physical function, pain-related cognitions and 
behaviours, and perceptions of their physical health.  However, only weak associations were found 
between scores on the QuIKS and the EQ-5D VAS, PASE, and SF-12v2 MCS measures.  These results 
do not support the convergent validity of the QuIKS.  Therefore, it is possible that health-related quality 
of life, physical activity levels, and self-perceived mental health are not captured in the illness behaviour 
construct.  
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Prior to this study, the QuIKS has only ever been compared to the Knee injury and Osteoarthritis 
Outcome Score (KOOS).  Clark and colleagues (2014) found statistically significant moderate 
correlations for each subscale of the original version of the QuIKS with the KOOS-sports and recreation 
function and the KOOS-quality of life subscales.  These correlation values ranged from 0.40 to 0.70 
(Clark, Chesworth, Speechley, Petrella, & Maly, 2014), but no correlation analysis was performed using 
the total QuIKS score.  Hamilton et al., (2015) compared total QuIKS scores to all sections of the KOOS, 
and found the lowest correlation was with the KOOS-other symptoms (rs = 0.45), followed by the 
KOOS-sports and recreation function (rs = 0.65), the KOOS-activities of daily living (rs = 0.70), the 
KOOS-pain (rs = 0.72), and the highest correlation was with the KOOS-quality of life (rs = 0.77).  Our 
results, despite finding a correlation of 0.46 with the KOOS-PS, are in line with previous convergent 
validity studies of the QuIKS.  
5.3 Discriminative Validity 
Eight discriminative validity hypotheses were created a priori.  The data suggests that the QuIKS is a 
valid measure of illness behaviour in this sample, as it was able to discriminate between most study 
groups, despite not matching the pre-specified hypotheses for magnitude of effect sizes between groups.  
Individuals with a previous diagnosis of knee OA scored significantly lower on the QuIKS than those 
with no formal diagnosis, indicating more illness behaviour in the group with a prior diagnosis of knee 
OA.  The effect size for this difference was d = 0.70, which was compared to the hypothesis of d = 0.80.  
Mean QuIKS scores were also significantly different between groups of differing levels of physical 
function, pain interference, pain severity, and physical health. The effect sizes for these groups were 
moderate, ranging from 0.46 to 0.69, which did not quite meet the hypothesized effect sizes, but does 
support the QuIKS ability to discriminate between these known-groups.  The ability of the QuIKS 
measure to discriminate between these groups is evident in the gradients found between groups in the 
box plots found in Figure 4.  Therefore, the discriminative validity results also support illness behaviour 
as a higher order construct that incorporates an individual’s physical function, pain-related cognitions 
and behaviours, and perceptions of their physical health. 
Conversely, mean QuIKS scores were unable to differentiate between groups of differing levels of 
health-related quality of life, as measured by the EQ-5D VAS, physical activity levels, as measured by 
the PASE, and mental health status, as measured by the SF-12v2 MCS.  No significant between-group 
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differences in QuIKS scores were found, indicating that illness behaviour may not capture elements of 
health-related quality of life, physical activity levels, and mental health status.   
Prior to this study, the discriminative validity of the QuIKS has only been evaluated in one other study.  
Hamilton et al., (2015) tested whether mean QuIKS scores were able to discriminate between known-
groups of individuals with differing severity of knee symptomology.  A statistically significant moderate 
effect size was found between individuals with healthy knees and those with knee pain, as well as 
between those with knee pain and individuals scheduled for surgical intervention.  These findings 
suggest that those with more severe knee disease exhibit more illness behaviour.  Our results reflect 
these findings, as those with a previous formal diagnosis of knee OA, likely indicating more chronic and 
severe disease, also exhibit significantly more illness behaviour.  While the effect sizes in our study are 
smaller than those found in the work by Hamilton et al., (2015), this is likely a result of the different 
samples studied.  Hamilton et al., (2015) used a spectrum of individuals ranging from healthy knees to 
those awaiting surgical intervention, where our study used a much more narrow sample.  All participants 
in our study must have had chronic knee symptoms, but not be awaiting surgical intervention.  The much 
more select group enrolled in this study likely decreased the variability between known-groups and 
therefore, smaller effect sizes are not surprising.  
5.4 Overall Construct Validity 
Overall, there appears to be some evidence to support the construct validity of the QuIKS, as a majority 
of the tests of convergent and discriminative validity were supportive, despite not meeting the pre-
specified hypotheses.  These findings should be considered strong, as this study followed the 
recommended design and reporting for construct validity studies (Terwee et al., 2007; Mokkink et al., 
2010).  The research team developed a priori hypotheses that included the direction and magnitude of 
correlations and expected differences in scores between known-groups.  Testing predefined hypotheses 
prevented retrospective rationalization of why a correlation value or effect size between groups may be 
low and incorrectly concluding the measure is valid.  Furthermore, this study reported the results of all 
tests of construct validity and not just those that were supportive. 
It has been proposed by Terwee et al., (2007) that in order to support the construct validity of a health 
measurement tool, at least 75% of the results must be in-line with predefined hypotheses, when tested in 
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at least 50 subjects.  None of the a priori hypotheses in our study were met, but the majority of tests had 
significant moderate correlations or effect sizes in the anticipated direction.  Moreover, these quality 
criteria were derived from expert opinion, as there is no empirical evidence to suggest that certain 
correlational or mean difference values must be attained to support construct validity (Terwee et al., 
2007).  Guyatt et al., (2002) also note that no specific correlation value is required for convergent 
validity, but moderate correlation values should be considered supportive.  Therefore, despite not 
meeting the expert quality criteria proposed by Terwee et al., (2007) the overall findings of this study do 
support the construct validity of the QuIKS.   
The results of both the convergent and discriminative validity tests using health status as measured by 
the EQ-5D VAS did not support the construct validity of the QuIKS.  Health status, or health-related 
quality of life, measured by the EQ-5D-5L, is a complex construct that is likely to be influenced by other 
contextual factors.  It may be that illness behaviour does not adequately assess these other factors, 
explaining the poor convergent and discriminative validity results.  However, it is possible that the EQ-
5D VAS is not a suitable measure of health status in those with knee OA, influencing the results of this 
study.  While the psychometric properties of the original EQ-5D-3L have been evaluated in knee OA 
populations, the validity of the EQ-5D-5L has not been as well established (Rolfson et al., 2016).  
Furthermore, visual inspection of the EQ-5D VAS data collected (Figure 3) shows an apparent ceiling 
effect, as the majority of respondents rated their health status between 80 and 100 on the scale.  Thus, the 
EQ-5D VAS data gathered in this study may not be a valid measure of health status, resulting in weaker 
than expected tests of convergent and discriminative validity.  
Additionally, both hypotheses for the convergent and discriminative validity of the QuIKS that involved 
physical activity levels measured by the PASE were not supported by the data. While it is possible that 
illness behaviour may not incorporate physical activity levels as we expected, the findings of this study 
may also be explained by the limitations of the PASE questionnaire.  The PASE questionnaire was 
originally developed to measure physical activity levels in individuals over the age of 65 years 
(Washburn, Smith, Jette, & Janney, 1993) and has demonstrated validity in some studies (Washburn, 
McAuley, Katula, Mihalko, & Boileau, 1999).  However, it is only weakly correlated with objective 
measures of physical activity in community-dwelling older adults (Logan, Gottlieb, Maitland, Meegan, 
& Spriet, 2013).  It is possible that the PASE is unable to accurately measure physical activity levels in 
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our sample, as we included individuals as young as 40 years of age and the average age of our sample 
was 60.3 years.   
The PASE may also have limited ability to accurately measure physical activity levels in an 
osteoarthritic population.  The PASE was found to have limited reliability and validity in individuals 
who have undergone total knee and total hip arthroplasty (Bolszak, Casartelli, Impellizzerri, & 
Maffiuletti, 2014; Casartelli, Bolszack, Impellizzeri, & Maffiuletti, 2015).  It has also been shown that 
the PASE is unable to assess physical activity levels for patients with hip OA (Svege, Kolle, & Risberg, 
2012).  As such, the PASE is not recommended as part of an international standard set of outcome 
measures for individuals with knee OA (Rolfson et al., 2016).  These studies call into question the ability 
of the PASE to accurately measure the physical activity levels of the individuals in our sample, and thus, 
may explain why the results of this study were not in line with the predefined hypotheses. 
Along with the EQ-5D VAS and PASE, the results from the convergent and discriminative tests using 
data from the SF-12v2 MCS did not support the construct validity of the QuIKS.  Mental health status 
may be influenced by a number of factors and may not be related to illness perception and behaviour.  
While the SF-12 has been recommended as a standard measure for individuals with knee OA (Rolfson et 
al., 2016), this recommendation appears to be based more so on the measurement properties of the 
original SF-36 (Kosinksi, Keller, Hatoum, Kong, & Ware, 1999).  It is possible the SF-12v2 may have 
limited measurement capabilities in a knee OA population, as there has been a lack of psychometric 
studies.  The unknown psychometric properties of the SF-12v2 may explain the lack of support for the 
construct validity of the QuIKS when using this measure in convergent and discriminative validity tests.   
5.5 Internal Consistency Reliability 
The secondary objective of this study was to estimate the internal consistency reliability of the QuIKS 
measure. Internal consistency reliability was estimated using Cronbach’s alpha, which was found to be 
0.81.  Therefore, the QuIKS appears to have good internal consistency reliability, as many sources cite 
0.80 as a minimum for a good research tool (Carmines & Zeller, 1979; Nunnally & Bernstein, 1994; 
Streiner 2003).  Moreover, it has been suggested that for measurement scales with 12 or more items, 
tested on less than 100 subjects, an internal consistency coefficient of 0.70 should be considered fair and 
0.85 should be considered excellent (Ponterotto & Ruckdeschel, 2007).  Lastly, the quality criteria for 
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health measurement tools developed by Terwee et al., (2007) suggest that a positive rating can be given 
for internal consistency reliability when Cronbach’s alpha is between 0.70 and 0.95.  
Prior to this study, the reliability of the QuIKS has only been evaluated on one other occasion.  Clark et 
al., (2014) evaluated the internal consistency reliability of each of the original QuIKS subscales 
individually.  All subscales of the original version of the QuIKS were shown to be internally consistent, 
as Cronbach’s alpha ranged from 0.73 to 0.87.   However, no other estimates of the internal consistency 
reliability are available when scoring all items on the QuIKS as a single scale.  No other comparison 
values of internal consistency are available in the literature, as no other knee OA screening tools have 
reported reliability estimates (LaValley et al., 2001; Marra et al., 2007; Quintana et al., 2007; Roux et al., 
2008).  Overall, the findings of this study are in-line with previous literature and support the internal 
consistency reliability of the QuIKS, as recommended minimum requirements were met while using 
recommended study methods.  
5.6 Limitations  
A limitation of this study is that the study participants in the sample did not receive a formal diagnosis of 
their knee complaint.  It is therefore possible that individuals may have knee pathology and symptoms 
unrelated to knee OA.  However, this is unlikely as the strict exclusion criteria were likely to have 
removed individuals with other causes of knee pain from the study sample. Furthermore, over 40% of the 
individuals in the sample reported having received a formal diagnosis of knee OA in the past. 
The number of participants completing questionnaires yielded a smaller sample size than indicated to test 
the predefined hypotheses.  This is likely due to the stringent eligibility criteria, as almost one-quarter of 
the individuals who were mailed a questionnaire package were deemed ineligible.  This may be a result 
of many individuals with chronic knee problems also having comorbid low back, hip, foot and ankle 
pain, or other health conditions making them ineligible to participate.  However, we were able to find 
statistically significant correlation values and effect sizes between known-groups when comparing the 
QuIKS to these individuals’ levels of physical function, pain interference, pain severity, and physical 
health status.  Furthermore, Terwee et al., (2007) suggest tests of construct validity be performed on 
groups of 50 or more individuals.  Fifty-five individuals completed the questionnaire package in this 
study. However, due to incomplete questionnaires, sample sizes in this study ranged from 44 to 50.  
	  71	  
While not meeting the recommended sample size by Terwee and colleagues (2007), our sample sizes 
were quite close and the addition of a few more participants to reach the 50 participant threshold is 
unlikely to significantly alter the findings of this study.   
Another limitation of this study is the use of distribution-based cut points to formulate the known-groups 
in the tests of discriminative validity.  Identifying known-groups using the distribution of scores in the 
sample to form tertiles may not be an accurate indication of the level of trait assumed in each group.  For 
example, when identifying three known-groups of physical function based on scores from the KOOS-PS, 
it is possible that the differences between the mean KOOS-PS scores in the high, medium and low 
physical function groups do not represent true differences in these individuals’ physical function level.  
This is evident in the three known-groups of health status based on scores from the EQ-5D VAS.  The 
ceiling effect in the scores on this measure resulted in three known-groups with roughly equivalent mean 
EQ-5D VAS scores, meaning these groups have essentially the same level of health status, but have been 
labeled high, medium, and low health status groups according to the distribution-based cut points.   
Ideally, the strongest study design would be to identify known-groups using previously defined and 
validated scoring-based cut points for these measures.  However, we are unaware of any literature that 
references scoring-based cut points for the measures included in this study.  We also included a 
comparison of known-groups of individuals with and without a formal diagnosis of knee OA, which was 
based on self-report from the participants and not using a measurement scale or cut points. The inclusion 
of this comparison between valid known-groups should be viewed as a strength of the discriminative 
validity analysis in this study. 
The findings of this study should be interpreted with caution due to the overall lack of measurement 
studies on most measures in knee OA populations.  As a result, the construct validity of the QuIKS has 
been established in our study using comparator measures that may have validity and reliability 
limitations themselves.  For example, the KOOS-PS is a relatively well-studied measurement scale and a 
recommended measure for function in knee OA (Rolfson et al., 2016), but also requires further 
evaluation of its measurement error, structural validity, cross-cultural validity, and construct validity 
(Collins, Prinsen, Christensen, Bartels, Terwee, & Roos, 2016).  However, we have used six different 
comparator measures and a known-group of individuals with and without knee OA to evaluate the 
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construct validity of the QuIKS.  The multiple tests of construct validity should reduce the potential bias 
from any one single comparator measure, enhancing the credibility of our results.  
Lastly, the major limitation of this study is that it represents only an initial step in the validation process 
of the QuIKS measure.  This study was the first evaluation of the construct validity of the QuIKS in an 
independent sample of individuals with chronic knee symptoms consistent with knee OA.  The sample of 
individuals in this study is only representative of those with knee symptoms likely due to OA and 
therefore requires many more validation steps prior to the implementation of the QuIKS into clinical 
practice.  The sample utilized in this study is not representative of the population for which the QuIKS 
may be used in the clinical setting.  For example, the QuIKS should be evaluated for its ability to 
discriminate illness behaviour between individuals with knee OA and other causes of knee symptoms, or 
even other unrelated health conditions.  Further evaluation of the QuIKS measurement tool, including 
diagnostic testing, must be performed prior to concluding the QuIKS is a valid measure of pre-diagnostic 
knee OA.    
5.7 Future Research 
While the results of this study support the construct validity of the QuIKS in this sample, this study did 
not assess the QuIKS ability to identify asymptomatic individuals. These results indicate that the QuIKS 
is a valid measure of illness behaviour in this sample and should serve as a framework for the future 
prospective evaluation of the QuIKS as a screening tool for knee OA.  The QuIKS could improve early 
detection of knee OA, as the questionnaire was developed using a cohort of individuals with emerging 
knee symptoms (Maly & Cott, 2009).  It would be of interest to follow a group of participants 
longitudinally to determine if QuIKS scores can be used to predict individuals who develop identifiable 
knee OA.  Further reliability assessments should also be conducted, including a test-retest assessment of 
the QuIKS to ensure the construct remains stable over a shorter time period.  Lastly, the QuIKS may 
have potential to be used as an evaluative measure to track response to various interventions, but 
assessment of the scales responsiveness to change is required.   
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Chapter 6 
6 Conclusion 
Knee OA is a highly prevalent condition and leading cause of disability in Canada (Bombardier, 
Hawker, & Mosher, 2011) and throughout the world (Vos et al., 2017).  While there is no gold standard 
diagnosis for OA, most current diagnostic procedures are designed to identify individuals in the later 
stages of the disease process (Burstein, 2009).  As a result, patient self-report screening measures for 
knee OA have not been designed to identify early-stage disease.  The QuIKS measure quantifies illness 
perception and behaviour in individuals with chronic knee symptoms indicative of knee OA (Hamilton, 
Wong, Gignac, Davis, & Chesworth, 2017) with the hope of identifying individuals earlier in the disease 
process than currently possible (Clark, Chesworth, Speechley, Petrella, & Maly, 2014).   
In order to accurately quantify illness behaviours in these individuals, we evaluated the psychometric 
properties of the QuIKS, namely the construct validity and internal consistency reliability.  While the 
magnitude of the relationships may not have been as large as originally hypothesized, the work in this 
thesis supports the construct validity and internal consistency reliability of the QuIKS and illness 
behaviour construct in individuals with chronic knee symptoms.  The findings of this study can be used 
to inform further psychometric evaluation and diagnostic testing of the QuIKS as a potential screening 
tool for knee OA.  A screening tool able to identify individuals earlier in the OA disease process would 
allow for more optimal patient care and evaluation of interventions that could potentially slow disease 
progression and prevent the development of long-term disability.   
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Appendix 1. Copyright agreement for Figure 1 (Maly & Cott, 2009)  
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Appendix 2. QuIKS and QuIKS-R  
Items and Response Structure of the Questionnaire to Identify Knee Symptoms and the 
Questionnaire to Identify Knee Symptoms – Rasch Validated 
Subsection and Items Response Structure and Scoring  
 
 QuIKS QuIKS-R 
 
 
Medications 
 
 
Never (0), Rarely (1), 
Sometimes (2), Often 
(3), Always (4) 
 
Never (0), Rarely (1), 
Sometimes (1), Often 
(1), Always (2) 
Take pills before doing some 
activities to prevent knee pain 
 
  
Take pills after doing some 
activities to  
reduce knee pain 
 
  
Carry pills in case knees start 
to hurt 
  
   
 
Monitoring 
 
 
Strongly Disagree (0), 
Disagree (1), Neutral 
(2), Agree (3), Strongly 
Agree (4) 
 
Strongly Disagree (0), 
Disagree (1), Neutral 
(1), Agree (1), Strongly 
Agree (2) 
Notice knee pain when 
kneeling 
 
  
Knee(s) feel stiff after sitting 
or standing 
 
  
Knee(s) hurt after sitting or 
standing 
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Interpreting 
 
 
Strongly Disagree (0), 
Disagree (1), Neutral 
(2), Agree (3), Strongly 
Agree (4) 
 
Strongly Disagree (0), 
Disagree (1), Neutral (1), 
Agree (1), Strongly 
Agree (2) 
Talk to family and friends 
about knee problems 
 
  
Consult doctor about knee 
problems  
  
 
Suspect knee problems are 
result of getting older 
 
  
Suspect knee problems are 
arthritis 
  
   
 
Modifying 
 
 
Strongly Disagree (0), 
Disagree (1), Neutral 
(2), Agree (3), Strongly 
Agree (4) 
 
Strongly Disagree (0), 
Disagree (1), Neutral (1), 
Agree (1), Strongly 
Agree (2) 
Participate in certain activities 
less due to knee problems 
 
  
Considering stopping a 
favourite activity due to knee 
problems 
 
  
Considering changing exercise 
routine due to knee problems 
 
  
Note. QuIKS= Questionnaire to Identify Knee Symptoms, QuIKS-R= Questionnaire to Identify Knee 
Symptoms – Rasch Validated.  
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Appendix 3. Letter of Information  
Study Title:  The QuIKS Knee Study, the Questionnaire to Identify Knee Symptoms (QuIKS) validation 
among physical therapy clients and people in the community  
 
Primary Researcher 
Dr. Bert Chesworth, PhD 
Associate Professor and Acting Director 
School of Physical Therapy 
Western University 
 
Study Coordinator &  
Graduate Student Researcher 
James Young, DC 
MSc candidate 
Graduate Program in  
Health and Rehabilitation Sciences 
Western University 
 
Co-Researcher 
Dr. Rob Petrella, MD, PhD 
Professor of Family Medicine, 
Rehabilitation, Kinesiology and 
Cardiology 
Western University 
 
Co-Researcher 
Dr. Dawn Gill, PhD 
Allied Scientist 
ARGC Research Centre, Lawson Health 
Research Institute 
 
Dear <<Name of prospective participant>>, 
 
Introduction 
We are writing to ask for your help in this study. This study aims to finalize the development of a health 
questionnaire to be used by clinicians to recognize the early symptoms of chronic knee pain problems in 
adults. We are contacting you because you sent us your contact information and indicated your interest 
in learning more about this study. The early recognition of chronic knee pain problems may play an 
important role in improving treatment of these problems. Early recognition may inform clinicians when 
providing therapy that should keep individuals with knee pain problems physically active for longer. The 
purpose of this letter is to provide information for potential participants to make an informed decision as 
to whether they want to participate in this study. 
 
Background and Purpose 
The Questionnaire to Identify Knee Symptoms (QuIKS) was recently developed from work done by 
health scientists at Western University in London, Ontario. For this questionnaire to provide evidence-
informed application in the health care of people with knee pain problems, it should undergo further 
validation through clinical research. Therefore, the purpose of this research study is to provide further 
evidence that this health questionnaire can accurately and precisely measure key aspects of people’s 
experience with knee pain problems. 
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Study Design  
Approximately 200 people from the community in London Ontario and surrounding areas and physical 
therapy clinics across Canada will take part in this research study. Participants will complete a set of 
questionnaires about their health.  
 
Inclusion Criteria 
You may be eligible to participate in this study if you are aged 40 through 79 years. Also, if you have 
had knee pain within the last year, and if you speak and understand the English language. 
 
Exclusion Criteria 
You are not eligible to participate in this study if your physician or a clinician told you that you have a 
neurological problem such as stroke, chronic obstructive pulmonary disease (COPD), rheumatoid 
arthritis, gout, ankylosing spondylitis, fibromyalgia, lupus, chronic back, hip or foot pain lasting six 
months or longer, an acute injury to the knee within the last six months, or a terminal condition. Also, 
you are not eligible to participate if you have had a total knee replacement or a high tibial osteotomy.   
 
Procedures 
If you agree to participate, you will be asked to respond to questions about your demographic 
characteristics (such as sex and age) and illness history (such as if you have a history of knee injury). 
This first questionnaire will take about 5 minutes to complete. If you meet the eligibility criteria of this 
study based on your history of illnesses, you will be asked to complete the six health questionnaires 
included with this letter. This one-time participation will take approximately 30 minutes. 
 
Voluntary Participation 
Participation is totally voluntary. Your decision to participate, or not to participate, will have no 
influence on the health care provided to you. You may refuse to participate in this study. If you withdraw 
your consent after returning your completed questionnaires, you will not be able to withdraw your data 
from this study once your data have been collected. 
 
Possible Risks and Harms 
There are no known or anticipated risks or discomforts associated with participating in this study. 
However, if you do experience any problems or discomfort, you may discontinue your participation at 
any time without penalty.  
 
Possible Benefits 
You may not directly benefit from participating in this study, but information gathered may provide 
benefits to society as a whole. However, you may benefit from the knowledge and experience gained 
when participating in this research, which could improve your understanding of knee pain problems.  
 
Reminders and Responsibilities 
Participants are required to complete the set of questionnaires included with this letter. Then, please 
return the completed questionnaires by mail within two weeks of receipt. We will send you a reminded 
next week to complete and return your set of questionnaires. If we don’t receive your set of completed 
questionnaires within three weeks of it being sent to you, we will contact you either by phone, or by 
mail, to remind you to complete and return your set of questionnaires. If for any reason you choose not 
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to participant in this study, please let us know by returning the questionnaires using the enclosed pre-
stamped envelope. 
 
Name of Sponsor 
This research study is not sponsored by any third party organization. 
 
Costs 
There is no direct cost to you for your participation in this research study. 
 
Compensation 
You will not be compensated for participating in this research study. 
 
Conflict of Interest 
The researchers declare that they have no conflict of interest in relation to this study.  
 
Confidentiality and Rights as a Participant 
Your confidentiality is important and will be respected. All data collected will remain confidential and 
accessible only by the researchers in this study. No information that discloses your identity will be 
released or published at any time. Your identity will be kept anonymous for all the health information we 
collect from you, using a four digit identification number unique to you. For the purpose of contacting 
you, your name and contact information will be kept on a master list safely stored on the secure 
password protected Western University server available to Dr. Chesworth at Elborn College located at 
Western University in London, Ontario, Canada. Your name, address and telephone number will be 
removed from the set of questionnaires received from you and the return envelope will be destroyed 
before we record you anonymized data. 
 
Your information will be kept confidential throughout this study, and at the end of this study, the master 
list with your name and any information linking you to any data collected will be destroyed. All data 
collected in this study will be analyzed in aggregate and any future publication or presentations of the 
results will not reveal your identity. Therefore, no information identifying you will be released or 
printed. Only group results will be reported and all de-identified hard copy of the information we 
collected from you will be destroyed 5 years after the project has been completed. When all information 
that could identify you is removed from the data you provide, an electronic record of the data will be 
stored indefinitely and used for future clinical research. 
 
Representatives of Western University’s Health Sciences Research Ethics Board may contact you or 
require access to your study-related records to monitor the conduct of this study.  
 
Questions about the Study 
This letter of information is yours to keep. If you require any further information regarding this research 
study or your participation in this study you may contact the primary researcher, Dr. Bert Chesworth, or 
the study coordinator, James Young.  
 
If you have any questions about your rights as a research participant or the conduct of this study, you 
may contact The Office of Research Ethics. 
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Consent 
You may indicate your voluntary agreement to participate by completing the questionnaires and signing 
the consent form. 
 
Thank you very much for considering to participate in this study. 
 
Sincerely, 
 
 
 
Bert Chesworth, PhD 
Primary Researcher 
Associate Professor and Acting Director 
School of Physical Therapy 
Western University 
London, Ontario 
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Appendix 4. Consent Form  
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Appendix 5. Western University Health Science Research Ethics Board 
Approval Notice  
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